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                                      1. INTRODUCTION 
1.1 Introduction to Analytical chemistry  
                                                           (P C Kamboj, 2003. Annees A. Siddiqui, 2006) 
   The pharmaceutical analysis defined as “the branch of practical chemistry 
which deals with the resolution, separation, identification, determination and 
purification of a given sample of a medicine, the detection and estimation of impurities, 
which may be present in drug substance (or) given sample of medicine”. The substance 
may be a single compound or a mixture of compounds and may be in the form a tablet, 
pill, capsule, ampoule, liquid, mixture or an ointment. 
The quality control tests involve methods which embrace chemicals, physio -
chemical/ instrumental, microbiological (or) biological procedures. 
The pharmaceutical analysis deals with the subject of determining the 
composition of material in terms of the elements or compound (drug) present in the 
system. 
Any type of analysis involves two steps 
Identification (qualitative) 
Estimation (quantitative) 
In qualitative analysis, a reaction is performed in such a way as to indicate the 
formation of a precipitate, a change of a colour , the dissolution of a precipitate/ 
complex formation and the evaluation of a gas. 
Quantitative analysis is performed ordinarily through five steps. They are 
sampling, dissolution, precipitation, measurement and calculation. 
Method of assay 
It indicates the quantitative determination of principal ingredients of the official 
substances and in preparations. 
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Qualitative analysis 
This is practiced in order to establish the composition of a naturally occurring or 
artificially synthesized/ manufactured substance. 
Qualitative analysis 
1. Chemical Methods 
a) Titrimetric analysis 
b) Gravimetric analysis 
c) Gasometric analysis 
2.  Physio - Chemical Methods (Instrumental Methods) 
3. Microbiological Procedures 
4. Biological Procedures 
I. Chemical Methods 
a. Titrimetric Analysis  
The analysis based on the fact that in all balanced chemical reactions utilized 
for the purpose. Equivalent weight of one substance reacts quantitatively with the 
equivalent weight of the other substance. The difference types of titration are as follows 
Acid base titrations (neutralization titrations) 
Non- aqueous titrations 
Redox titrations (redox = oxidation - reduction) 
Precipitation titrations 
Complexometric titrations 
b. Gravimetric Analysis 
This method involves the conversion of the element or a radical to be 
determined into a pure stable compound readily convertible into a form suitable for 
weighing. 
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c. Gasometric Analysis 
 This type of analysis involves the measurement of the volume of gases. The 
volume of a gas set free in a given chemical reaction under the conditions similar to 
those described in the process. It may be noted that the volume of gas is taken at  
normal conditions and pressure or standard temperature and pressure (NTP/ STP) 
which is a temperature of 0
0
C (273.09
o
 K) and the pressure of a column of    760mm/ 
Hg at 0
0
C. If the reaction is taken place under different temperature and pressure the 
volume is adjusted to standard conditions. A decrease in the volume of gas when a 
suitable reagent is placed to absorb one of the gases present. This decrease in volume is 
also reduced to STP. 
The gases cyclopropane, CO2, NO2, oxygen, octyl nitrite, Nitrogen,           amyl 
nitrite, ethylene and helium are determined by gasometric analysis. The measurement 
of volume of gases is usually done by means of gas burettes or nitrometers. 
II. Physio - Chemical Methods (Instrumental Methods) 
Initially analytical methods were depending on extraction procedure, volumetric 
and gravimetric methods. All these methods are nearly replaced by advanced 
instrumental methods. These methods are more sensitive, specific and accurate but cost 
factors of the instruments and their maintenance are the main draw backs. Various 
instrumental methods are classified depending on the property analyzed. 
Shows different instrumental methods with basic principle 
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Sr. N0. MEHTOD BASIC PRINCIPLE 
A ELECTROANALYTICAL METHODS 
1 Potentiometry 
Concerned with change in electrical properties 
of the system measures the change in 
electrode potential during a chemical reaction 
of the system 
2 Conductometry 
Measures the change in electrical conductivity 
during a chemical reaction 
3 Polarography 
Measure the current at various applied 
potential indicating the polarization at 
indicator electrode 
4 Amperometry 
Measure the change (or decrease) in current at 
a fixed potential during addition of titrant 
B SPECTROSCOPIC METHODS 
1 
Absorption Spectroscopy 
(Ultraviolet-Visible and 
Infrared) 
Measure the absorbance or percent 
transmittance during the interaction of 
monochromatic radiation (or particular 
wavelength) by the same 
2 Fluorimetry 
Measure the intensity of fluorescence caused 
by emission of electromagnetic radiation due 
to absorption of UV radiation 
3 Flame Photometry 
Measure the intensity of emitted light of 
particular wave length emitted by particular 
element 
4 Turbidimetry 
Measure the turbidity of a system by passing 
light beam in a turbid media 
5 Nephlometry 
Measure the opalescence of the medium by 
reflection of light by a colloidal solution 
6 Atomic Absorption Measure the intensity of absorption when 
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Spectrometry atoms absorbs the monochromatic radiation 
7 X-Ray Spectroscopy 
Measure the position and intensity of spectral 
lines during emission of X ray spectrum by 
atoms under influence of X rays 
8 Refractometry 
Measure the refractive index by causing 
refraction of light by matter 
9 Polarimetry 
Measure optical reaction by causing the 
rotation of plane polarized light 
C Mass Spectroscopy 
Observe the position and intensity of signals 
in mass spectrum by causing the ionization of 
molecules 
D NMR Spectroscopy 
Observe the position and intensity lines in 
NMR spectrum when proton interact with 
electromagnetic radiation in radio frequency 
region 
E Thermal Methods 
Measure the physical parameters of the system 
as a function of temperature. It includes 
thermo gravimetry, derivative gravimetry, 
differential thermal analysis 
F Radiometric Methods 
Measure the radioactivity either present 
naturally or induced artificially 
 
III. Microbiological Methods 
`In a microbiological assay, a comparison of inhibition of the growth of bacteria 
by a measured concentration of the antibiotic, which is to be examined, is made with 
that produced by known concentration of the standard preparation of an antibiotic 
having known activity. 
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IV. Biological Methods 
When the potency of a drug or its derivative cannot be properly determined by 
physical or chemical methods and where it is possible to observe the biological effects 
of the drug on some type of living matter. The biological assays are carried out. The 
basis of such assay is to determine how much of the sample gives the same biological 
effect as a given quantity of the standard preparation. The sample and standard 
preparation are tested under identical conditions in all respect. In a typical bio – assay, 
a stimulus is applied to a subject is referred to as the dose and is indicated by a weight 
or in terms of the concentration of the preparation. The application of stimulus on a 
subject produces some observable effect and this is called the response. The response 
may be measured by the total weight or weight of some organ of the subject, blood 
sugar concentration, diameter of inhibition zone or by some other physiological 
symptoms. 
1.2.1 ULTRAVIOLET SPECTROSCOPY        (Beckett and Stenlake, 2002)
 This technique of ultra violet spectroscopy is one of most frequently employed 
method in pharmaceutical analysis. It involves the measurement of the amount of UV 
radiation (190 - 380 nm) or visible (380 - 800 nm) radiation absorbed by a substance in 
solution. Ultraviolet spectroscopy involves the promotion of electrons (σ, π, n 
electrons) from the ground state to higher energy state. It is useful to measure the 
number of conjugated double bonds and also aromatic conjugation with the various 
molecules. 
  The ultraviolet region of the electromagnetic spectrum is frequently subdivided 
into as follows: 
 Far vacuum Ultraviolet region (10 - 200 nm) 
 Near ultraviolet region (200 - 400 nm) 
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 Visible region (380 - 780 nm) 
Origin and theory of ultraviolet spectra  (Gurdeep R. Chatwal, et al., 2000) 
 Ultraviolet absorption spectra arise from transition of electron (or) electrons 
with in a molecule or an ion from a lower to a higher electron energy level and the 
ultraviolet emission spectra arise from the reverse type of transmission. For radiation to 
cause electronic excitation it must be in the UV region of the electromagnetic spectrum. 
 Energy absorbed in the ultraviolet region produces change in the electronic 
energy of the molecule resulting from transition of valence electrons in the molecule. 
Three distinct types of electrons are involved in organic molecule. These are as follows 
σ – Electrons 
 Theses electrons are involved in saturated bonds, such as those between carbons 
and hydrogen in paraffins. These bonds are known as σ bonds. As the amount of energy 
required to excite electron in σ bonds is much more than that produced by UV light, 
compounds containing σ bonds do not absorb UV radiation. These electrons do not 
absorb near UV radiation but absorb at vacuum UV radiation.   
π – Electrons  
 These electrons are involved in unsaturated hydrocarbons. Typical compounds 
with π bonds are trienes and aromatic compounds. 
n– Electrons  
 These electrons are non bonded electrons which are not involved in any bonding 
between atoms in molecules. (eg.) S, O, N and halogens. 
Types of Electronic Transitions (Y.R. Sharma, 2009) 
 A molecule is excited by the absorption of energy (UV or Visible light). Its 
electrons are promoted from a bonding to an anti bonding orbital. 
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i. The anti bonding orbital which is associated with the excitation of σ – electrons 
is called σ* anti bonding orbital. So σ to σ* transition take place when σ (sigma) 
electron is promoted to antibody (σ) orbital. It is represented as σ         σ* 
transition. 
ii. When a non - bonding electron gets promoted to an antibody sigma orbital (σ*) 
then it represents n - σ* transition. 
iii. Similarly π         π* transition represents the promotion of π electrons to an anti 
bonding π orbital π* orbital. 
iv. When an n- electron (non- bonding) is promoted to anti bonding π orbital. It 
represents n         π* transition. 
 
 
Electronic excitation energies 
a) σ         σ* transition  
  The organic compounds in which all the valence shell electrons are involved in 
the formation of sigma bonds do not show absorption in the normal ultraviolet region, 
but occur in vacuum UV region (125 - 135). 
e.g. methane, ethane, propane, cyclopropane. 
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b) n         σ* transition 
 This type of transition takes place in saturated compounds containing one hetero 
atom with unshared pair of electrons (n electrons). 
e.g. alcohol, ethers, aldehydes, ketones, amines etc., 
 Such transition require comparatively less energy than that required for σ     σ* 
transitions. 
c) π         π* transition 
 This type of transition occurs in the unsaturated centers of the molecule in 
compounds containing double or triple bonds and also in aromatics. The excitation of π 
electrons smaller energy and hence transition of this type occurs at longer wavelength. 
e.g. alkenes, alkynes, carbonyl compounds, cyanides. 
d) n         π* transition 
 In this type of transition an electron of unshared electron pair on hetero atom 
gets excited to π* anti body orbital. This type of transition requires least amount of 
energy out of all the transitions.. 
The absorption laws (Y.R. Sharma, 2009) 
 There are two laws which govern the absorption of light by the molecules. 
These are, 
(1) Lambert‟s Law 
(2) Beer‟s Law 
Lambert’s Law 
 When a beam of monochromatic radiation passes through a homogenous 
absorbing medium, the rate of decrease of intensity of radiation with thickness of 
absorbing medium is proportional to the intensity of incident radiation. 
I = I0e
-kt 
Where,  I0 = Intensity of incident light 
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  I = Intensity of emerged light 
  t = Thickness of the medium 
Beer’s Law  
When a beam of monochromatic radiation is passed through a solution of an absorbing 
substance, the rate of decrease of intensity of radiation with concentration of the 
absorbing solution is directly proportional to the intensity of incident radiation.  
I = I0e
-kc
 
Where,  I0 = intensity of incident light 
 I = Intensity of emerged light 
 c = concentration of the absorbing species 
From these laws, the following empirical expression of Beer - Lambert‟s Law was 
constructed 
                                              Log (I0/IT) = Єct =A 
Where,  A= Absorbance or optical density or extinction co-efficient 
 Є = Molecular extinction co-efficient 
  c = Concentration of drug  
  t = Path length 
Limitations of Beer Lambert’s Law  
1. When different forms of the absorbing molecules are in equilibrium as in keto-
enol tautomers. 
2. When fluorescence compounds are present. 
3. When solute and solvent forms complex through some sorts of association. 
Deviations from Beer’s Law (Gurdeep R. Chatwal, et al., 2000) 
 According to Beer‟s law, a straight line passing through the origin should be 
obtained, when a graph is plotted between absorbance and concentration. But there is 
always a deviation from linear relationship between absorbance and concentration and 
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intact the shape of an absorption curve usually changes with changes in concentration 
of solution and unless precautions are observed. Deviations from the law may be 
positive or negative according to whether the resulting curve is concave upward or 
concave downward.                              
 
The latter two are generally known as instrumental deviation and chemical deviation. 
Instrumental deviations 
 Stray radiation, improper slit width, fluctuation in single beam. 
Chemical deviations 
 Hydrolysis, Association, Polymerization, Ionization, Hydrogen bonding. 
Deviations from Beer’s Law can arise due to the following factors 
1. Beer‟s law will hold over a wide range of concentration provided the 
structure of coloured ion or of the coloured non electrolyte in the dissolved 
state does not change with concentration. If a coloured solution is having a 
foreign substance whose ions do not react chemically with the coloured 
components, its small concentration does not affect the light absorption and 
may also alter the value of extinction co - efficient. 
2. Deviations may also occur if the coloured solute ions dissociates or 
associates. 
3. Deviations may also occur due to the presence of impurities that 
fluorescence or absorb at absorption wavelength. 
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4. Deviations may occur if monochromatic light is not used. 
5. Deviations may occur if the width of slit is not proper and therefore it 
allows undesirable radiations to fall on the detector. 
6. Deviations may occur if the solution undergoes polymerization. 
7. Beer‟s law cannot applied to suspensions but the latter can estimated 
calorimetrically after preparing a reference curve with known 
concentrations. 
Choice of solvent (Gurdeep R. Chatwal, et al., 2000) 
 A suitable solvent for ultraviolet spectroscopy should meet the following 
requirements. 
(i) It should not itself absorb radiations in the region under investigation. 
(ii) It should be less polar so that it has minimum interaction with the solute molecule. 
The most commonly employed solvent is 95% ethanol. It is cheap, has good dissolving 
power and does not absorb radiation above 210 nm. In other words it is transparent 
above 210 nm. Commercial ethanol should not be used as it contains some benzene 
which undergoes absorption in the UV range at about 280.Some other solvents which 
are transparent above 210 nm are n-hexane, cyclohexane, methanol, water and ether, 
Benzene, chloroform, and carbon tetrachloride cannot be used because they absorb in 
the range of about 240 - 280 nm.Hexane and other hydrocarbon are sometimes 
preferred to polar solvents because they have minimum interaction with the solute 
molecules. 
Solvent Effects 
 The position and the intensity of absorption maximum is shifted for a particular 
chromophore by changing the polarity of the solvent. By increasing the polarity of 
solvent, compounds like dienes and conjugated hydrocarbons do not experience any 
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appreciable shift. The absorption maximum for the polar compounds is usually shifted 
with the change in polarity of the solvents. α and β unsaturated carbonyl compounds 
show two different shifts. 
 
a) n         π* transition  
The absorption band moves to short wavelength by increasing the polarity of the 
solvent. In n         π* transition the ground state is more polar as compared to the 
excited state. The hydrogen bonding with solvent molecules take place to lesser extent 
with the carbonyl group in the excited state. 
b) π         π* transition 
The absorption band moves to longer wavelength by increasing the polarity of the 
solvent. The dipole interactions with the solvent molecules lower the energy of the 
excited state more than that of the ground state. 
CHROMOPHORES AND AUXOCHROMES (Jagmohan, 2005) 
A. Chromophores 
“The presence of one or more unsaturated groups responsible for electronic 
absorption is called as chromophores”. 
e.g. C = C, C ≡ C, C = N, C ≡ N, C = O 
B. Auxochromes 
An Auxochrome is an auxiliary group which interacts with the chromophore 
causing a bathochromic shift. The presence of Auxochrome causes a shift in the UV or 
Visible absorption maximum to the longer wavelength. 
e.g. NH2, NR2, OH, OR, SH, NHR.  
 
 
14 
 
INSTRUMENTATION (Gurdeep R. Chatwal, et al., 2000) 
All photometers, colorimeters and spectrophotometers have the following basic 
components 
1) Radiation Source  
i) It must be stable. 
ii) It must be of sufficient intensity for the transmitted energy to be detected at  
the end of the optical path. 
iii) It must supply continuous radiation over the entire wavelength region in  
which it is used. 
UV region  
  Tungstan lamp, Hydrogen discharge lamp, Deuterium discharge lamp, Xenon 
arc Lamp. 
2) Filters and monochromatoros 
 The filters and monochromators are used to disperse the radiation according to 
the wavelength. The essential of a monochromator are an entrance slit, a dispersing 
element and an exit slit. The entrance slit sharply defines the incoming beam of 
heterochromatic radiation. The dispersing element disperses the heterochromatic 
radiation into its component wavelengths where as exit slit allows the nominal 
wavelength together with a band of wavelength on either side of it. The position of the 
dispersing element is always adjusted by rotating it to vary the nominal wavelength 
passing through the exit slit.  
UV region  
The dispersing element may be a prism or grating. The prisms are generally 
made of glass, quartz or fused silica. Glass has the highest resolving power but it is not 
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transparent to radiation having the wavelength between 2000 and 3000 A
 
because glass 
absorbs strongly in this region. Quartz and fused silica prism which are transparent 
throughout the entire UV range are widely used in UV spectrophotometers.  
Types of monochromators 
 1) Prisms 
 2) Gratings  
1) Prisms are of two types 
  i) Refractive prism 
 ii) Reflective prism 
2) Gratings are of two types 
 i) Diffraction grating 
 ii) Transmission grating 
Visible region 
 Filters or monochromators or both are used  
Filters  
 A light filter is a device that allows light of the required wavelength to pass but 
absorbs light of other wavelengths wholly or partially. Thus, a suitable filter can be 
select a desired wavelength band. It means that a particular filter may be used for a 
specific analysis. If analysis is carried out for several species, a large number of filters 
have to be used and interchanged. This method is very useful for routine analysis. 
Types of filters 
 Filters are two types, 
 i) Absorption filters 
ii) Interference filters 
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3) Sample cell 
These are containers for the sample and reference solutions and must be 
transparent to the radiation passing through. 
UV region  
The cells made up of quartz. 
Visible region  
The cells made of glass. 
4) Detectors 
Detectors used in UV/Visible spectrophotometers can be called as photometric 
detectors. In these detectors the light energy is converted to electrical signal which can 
be recorded. The types of detectors used are   
Barrier Layer cell (or) Photo Voltaic cell. 
Photo tubes (or) Photo emissive tubes 
Photomultiplier tubes  
Photo diode 
 QUANTITATIVE SPECTROPHOTOMETRIC METHODS (Beckett and 
Stenlake, 2002) 
 The assay of an absorbing substance may be quickly carried out by preparing a 
solution in a transparent solvent and measuring its absorbance at a suitable wavelength. 
The wavelength normally selected is a wavelength of maximum absorption (max), 
where small errors in setting the wavelength scale have little effects on the measured 
absorbance. 
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a. Assay of substances in single component samples 
 Absorption spectroscopy is one of the most useful tools available to the chemist 
for quantitative analysis. The most important characteristics of photometer and 
spectrophotometric method are high selectivity and ease of convenience. Quantitative 
analysis (assay of an absorbing substance) can be done using following methods. 
-    Use of A1 cm
1%   values 
-    Use of calibration graph (multiple standard method) 
-     By single or double point standardization method. 
i)  Use of 𝐀𝟏 𝐜𝐦
𝟏%   values 
 This method can be used for estimation of drug from formulations or raw 
material, when reference standard not available. The use of standard value A1 cm
1%  avoids 
the need to prepare a standard solution of the reference substance in order to determine 
its absorptivity, and is of advantage in situations where it is difficult or expensive to 
obtain a sample of the reference substance. 
ii. Use of calibration graph 
 In this procedure the absorbances of a number (typically 4-6) of standard 
solutions of the reference substance at concentrations encompassing the sample 
concentrations are measured and a calibration graph is constructed. The concentration 
of the analyte in the sample solution is read from the graph as the concentration 
corresponding to the absorbance of the solution. Calibration data are essential if the 
absorbance has a non-linear relationship with concentration, or if the absorbance or 
linearity is dependent on the assay conditions. In certain visible spectrophotometric 
assays of colourless substances, based upon conversion to coloured derivatives by 
heating the substance with one or more reagents, slight variation of assay conditions, 
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e.g. P
H
, temperature and time of heating, may rise to a significant variation of 
absorbance, and experimentally derived calibration data are required for each set of 
samples. 
iii. Single  point standardization 
          The single point procedure involves the measurement of the absorbance of a 
sample solution and of a standard solution of the reference substance. The standard and 
the sample solution are prepared in similar manner; ideally the concentration of the 
standard solution should be close to that of the sample solution. The concentration of 
the substance in the sample is calculated using following formula. 
                                    Ctest = A test × Cstd / Astd 
Where,  
Ctest and Cstd are the concentration in the sample and standard solutions 
respectively.  
Atest and Astd are the absorbance of the sample and standard solutions 
respectively    
b. Assay of substances in multi component samples 
             The spectrophotometric assay of drugs rarely involves the measurement of 
absorbance of samples containing only one absorbing component. The pharmaceutical 
analyst frequently encounters the situation where the concentration of one or more 
substances is required in samples known to contain other absorbing substances which 
potentially interfere in the assay. Unwanted absorption from these sources is termed 
irrelevant absorption and if not removed, imparts systematic errors to the assay of the 
drug in the sample. A number of modifications to the simple spectrophotometric 
procedure for single-component samples are available to the analyst, which may 
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eliminate certain sources of interferences and permit the accurate determination of one 
or all of the absorbing components. 
            The basis of all the spectrophotometric technique for multicomponent samples 
is the property that at all wavelengths: 
a)   The absorbance of a solution is the sum of absorbances of the                 
individual components. 
b)   The measured absorbance is the difference between the total absorbance 
of the solution in the sample cell and that of the solution in the reference 
(blank) cell. 
The determination of the multi-component samples can be done by using the following 
methods, 
 Simultaneous equation method 
 Absorbance ratio method 
 Geometric correction method 
 Orthogonal polynomial method 
 Difference spectrophotometry 
 Derivative spectrophotometry 
 Chemical derivatization 
1.2.2 Derivative Spectrophotometry 
Derivative spectrophotometry involves the conversion of a normal spectrum to 
its first, second or higher derivative spectrum. The transformations that occur in the 
derivative spectra are understood by reference to a Gaussian band which represents an 
ideal absorption band. In the context of derivative spectrophotometry, the normal 
absorption spectrum is referred to as the fundamental, zeroth order or D° spectrum. 
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The first derivative (D
1
) spectrum is a plot of the ratio of change of absorbance 
with wavelength against wavelength, i.e. a plot of the slope of the fundamental 
spectrum against wavelength or a plot of dA/dλ Vs λ. At λ2 and λ4, the maximum 
positive and maximum negative slope respectively in the D°. Spectrums correspond 
with maximum and a minimum respectively in the D
1
 spectrum. The λmax at λ3 is a 
wavelength of zero slopes and gives dA/d λ 0, i.e. a cross-over point, in the D1 
spectrum.  
The second derivative (D
2
) spectrum is a plot of the curvature of the D° 
spectrum against wavelength or a plot of d
2A/dλ2Vs λ. The maximum negative 
curvature at λ3 in the D° spectrum gives a minimum in the D
2
 spectrum, and at λ1 and 
λ5 the maximum positive curvature in the D° spectrum gives two small maxima called 
„satellite‟ bands in the D2 spectrum. At λ2 and λ4 the 
 
Figure. The zeroth (a), first (b) and second (c) derivative spectra of a Gaussian 
band.Wavelengths of maximum slope and zero curvature in the D° spectrum 
correspond with cross-over points in the D
2
 spectrum. 
21 
 
In summary, the first derivative spectrum of an absorption band is characterized 
by a maximum, a minimum, and a cross-over point at the λmax of the absorption band. 
The-second derivative spectrum is characterized by two satellite maxima and an 
inverted band of which the minimum corresponds to the λmax of the fundamental band.  
These spectral transformations confer two principal advantages on derivative 
spectrophotometry. Firstly, an even order spectrum is of narrower spectral bandwidth 
than its fundamental spectrum. Secondly, derivative spectrophotometry discriminates in 
favour of substances of narrow spectral bandwidth against broad bandwidth substances. 
This is because „the derivative amplitude (D), i.e. the distance from a maximum to a 
minimum, is inversely proportional to the fundamental spectral bandwidth (14‟) raised 
to the power (n) of the derivative order 
. Thus,              D α (1/W)n 
Consequently, substances of narrow spectral bandwidth display larger derivative 
amplitudes than those of broad bandwidth substance 
 
(a) The individual spectra of two components X and Y in admixture and their 
combined spectrum. (b) The second derivative spectrum of the mixture showing 
improved resolution of the individual bands.  
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The enhanced resolution and bandwidth discrimination increases with 
increasing derivative order. However, it is also found that the concomitant increase in 
electronic noise. Inherent in the generation of the higher order spectra, the consequent 
reduction of the signal-to-noise ratio, place serious practical limitations on the higher 
order spectra. 
1.3 HIGH PERFORMANCE LIQUID CHROMATOGRAPHY 
1.3.1 Introduction to chromatography (Gurdeep R. Chatwal, et al., 2000) 
Chromatography may be defined as a method of separating a mixture of components 
into individual components through equilibrium distribution between two phases. 
Chromatographic technique is based on the difference in the rate at which the 
components of a mixture move through a porous medium (stationary phase) under the 
influence of some solvent or gas (mobile phase). 
   The chromatographic method of a separation, in general, involves the following 
steps 
1. Adsorption or retention of a substance or substance on the stationary phase. 
2. Separation of the adsorbed substance by the mobile phase. 
3. Recovery of the separated substance by a continuous flow of the mobile            
phase; the method being called elution. 
4. Quantitative and qualitative analysis of the eluted substance 
1.3.2. Introduction to HPLC (B.K. Sharma, 2006)                                                                                           
HPLC is a form of liquid chromatography to separate compounds that are dissolved in 
solution. Compounds are separated by injecting a plug of the sample mixture on to the 
column. The different compounds in the mixture pass through the column of different 
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rates due to difference in their partitioning behavior between the mobile liquid phase 
and the stationary phases. 
Advantages: 
 Separation is fast and efficient 
 Continuous monitoring of the column effluent 
 Can be applied to the separation and analysis  of very complex mixture 
 Accurate quantitative measurements 
 Repetitive and reproducible analysis using the same column 
 Adsorption, partition, ion exchange and exclusion column separations are 
excellently made 
 Automation of the analytical procedure and data handling 
 Both aqueous and non aqueous samples can be analysed 
 Providing a high degree of selectivity for specific analysis 
 Determination of multiple components in a single analysis 
1.3.2.1. Principle of separation in HPLC (Willard, 1986) 
The principle of separation in normal phase and reverse phase mode is the 
adsorption. When a mixture of components is introduced in to a HPLC column, they 
travel according to their relative affinities towards the stationary phase. The component 
which has more affinity towards the adsorbent travels slower. The components     
which have less affinity towards the stationary phase travel faster. Since                                 
no two components have the same affinity towards the stationary phase the components 
are separated. 
Types of HPLC techniques  
a) Based on modes of chromatography 
 Normal phase mode 
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 Reverse phase mode 
b) Based on principle of separation 
 Adsorption chromatography 
 Ion exchange chromatography 
 Ion pair chromatography 
 Size exclusion or gel permeation chromatography 
 Affinity chromatography 
 Chiral phase chromatography 
c) Based on elution technique 
 Isocratic separation 
 Gradient separation 
d) Based on scale of operation 
 Analytical HPLC 
 Preparative HPLC 
Normal phase chromatography  
In normal phase mode, the stationary phase (silica gel) is polar in nature and 
the mobile phase is non-polar. In this technique, non-polar compounds travel faster 
and eluted first. This is because of less affinity between solute and stationary phase.   
Polar compounds are retained for longer time in the column because of more affinity 
towards stationary phase and take more time to be eluted from column. 
Reverse phase chromatography 
  In reverse phase technique, a non polar stationary phase is used. The mobile 
phase is polar is in nature hence polar components get eluted first and non-polar 
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compounds are retained for a longer time. Since most of the drugs and pharmaceuticals 
are polar in nature, they are not retained for a longer time and eluted faster, which is 
advantageous. Different columns used are ODS (octadecyl silane) or C18, C8 and C4 etc. 
Adsorption chromatography 
  The principle of separation is adsorption. The separation of components takes 
place because of the difference in affinity of compounds towards stationary phase. 
Ion exchange chromatography 
The principle of separation is ion exchange which is reversible exchange of 
functional groups. In ion exchange chromatography, an ion exchange resin is used to 
separate a mixture of similar charged ions. 
Ion pair chromatography 
In ion pair chromatography a reverse phase column is converted temporarily in 
to ion exchange column by using ion pairing agents like pentane, hexane, heptanes, 
octane, sulphonic acid sodium salt, tetramethyl or tetraethyl ammonium hydroxide. 
Size exclusion or gel permeation chromatography 
 In this type of chromatography, a mixture of components with different 
molecular sizes are separated by using gels. The gel used acts as molecular sieve and 
hence a mixture of substance with different molecular sizes is separated. Soft gels like 
dextran, agarose or polyacrylamide are used. Semi rigid gels like polystyrene, alkyl 
dextran in non aqueous medium are also used. 
 
 
26 
 
Affinity chromatography 
 Affinity chromatography uses the affinity of the sample with specific stationary 
phase. This technique is mostly used in the field of biotechnology, microbiology, 
biochemistry. 
Chiral phase chromatography 
 Separation of optical isomer can be done by using chiral stationary phases. 
Different principles operate for different types of stationary phases and for different 
samples. The stationary phases used for this type of chromatography are mostly 
chemically bonded silica gel. 
Isocratic separation 
 In this technique, the same mobile phase combination is used throughout the 
process of separation. The same polarity or elution strength is maintained throughout 
the process. 
Gradient separation 
 In this technique, a mobile phase combination of lower polarity or elution 
strength is used followed by gradually increasing the polarity or elution strength. 
Analytical HPLC 
 Where only analysis of the samples are done. Recovery of the samples for        
re using is normally not done, since the sample used is very low. e.g. µg quantities. 
Preparative HPLC 
 Where the individual fractions of pure compounds can be collected using 
fraction collector. The collected samples are reused. eg. Separation of few grams of 
mixtures by HPLC.   
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HPLC instrumentation 
Mobile phase (Mendham, et al., 2002) 
 A successful chromatographic separation depends upon difference in the 
interaction of the solutes with the mobile phase and stationary phase, and in liquid 
chromatography the choice and variation of the mobile phase is of critical importance 
in achieving optimum efficiency. However, before considering the theoretical aspects 
of solvent choice, here are a few general comments; HPLC grade solvents tend to be 
costly. To ensure consistent performance, the solvent needs to contain no more than 
trace amounts of other materials, including water for organic solvents. And if the 
system uses a UV detector then even small traces of absorbing species will be 
unacceptable; they must be exhaustively removed. Particulates in the solvent are also 
highly undesirable, with prolonged use they will lead to wear in the pump and injector 
and cause blockage of the column. 
 Although normal laboratory grade solvents could be suitably purified, this is a 
time consuming step and many laboratories prefer to purchase HPLC grade reagents, 
including water. HPLC grade reagents can be used directly without further purification, 
although they may need to degassed immediately before use. 
 The choice of a suitable mobile phase is vital in HPLC and it is appropriate to 
refer to the factor influencing this choice. Thus, the eluting power of the mobile phase 
is determined by its overall polarity, the polarity of the stationary phase and the nature 
of the sample components. For normal phase separations, eluting power increases with 
increasing polarity of the solvent, for reverse phase separations, eluting power decrease 
with increasing solvent polarity.    
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Solvent Reservoir (Ashutoshkar, 2005) 
   Solvent reservoir comprises of a 1dm
3
 glass bottle having lid and a 1/8 inch diameter 
ptfc tube to convey the mobile phase from the reservoir to the degassers and then to the 
pump. As described above, any liquid entering the pump should be free from dust and 
particulate matter, otherwise these foreign substance may invariably give rise to 
irregular pumping action, damage seals and valves, irregular behavior of column owing 
to its contamination, and ultimate blockade of column. Sometimes a stainless steel filter 
element (of filter size 2 μm) that could be conveniently positioned either in the ptfe - 
tube in the reservoir or an in - line filter may be employed. 
Degassing System                         
Many liquids dissolve appreciable amounts of atmospheric gases e.g. air or 
suspended air bubbles that may be a major cause of practical problems in HPLC, 
specifically affecting the operation of the pump and the detector. However, all such 
problems may be avoided by degassing the mobile phase by subjecting the mobile 
phase under vacuum, distillation, spurging with a fine spray of an inert gas of low 
solubility such as Argon or Helium or by heating and ultra sonic stirring.  
Pumping Systems (Douglas A. Skoog, 2005) 
 The requirements for liquid chromatographic pumps include  
a) Ability to generate pressure of up to 6000 psi (Lb/in2) 
b) Pulse free out put 
c) Flow rates ranging from 0.1 to 10 mL/min 
d) Flow reproducibilities of 0.5% relative or better 
e) Resistance to corrosion by a variety of solvents 
Types of pumps 
1. Reciprocating piston pump 
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2. Syringe – type pump 
3. Constant pressure pump 
Sample injection system (Mendham, et al., 2002) 
 Introduction of the sample is generally achieved is one of two ways, either by 
using syringe injection or through a sampling valve. Septum injectors allow sample 
introduction by a high pressure syringe through a self sealing elastomer septum. One of 
the problem associated with septum injectors is the leaching effect of the mobile phase 
in contact with the septum, which may give rise to ghost peaks. In general, syringe 
injection for HPLC is more trouble same than in gas chromatography. 
 Although the problems associated with septum injectors can be eliminated by 
using stop flow septum less injection. Currently the most widely used devices in 
commercial chromatographs are the micro volume sampling valves. Which enable 
sample to be introduced reproducibly in to pressurised columns without significantly 
interrupting the flow of the mobile phase. The sample is loaded at atmospheric pressure 
in to an external loop in the valve and introduced into the mobile phase by an 
appropriate rotation of the valve. The volume of sample introduced, ranging from 2 µl 
to over 100 µl, may be varied by changing the volume of the sample loop or by using 
special variable volumes sample valves. Automatic sample injectors are also available 
which allow unattended operation of the instrument. Valve injection is preferred for 
quantitative work because of its higher precision compared to syringe injection. 
Columns for HPLC (Willard, 1986) 
 Columns are constructed of heavy wall, glass lined metal tubing or stainless 
steel tubing to withstand high pressures (up to 680 atm) and the chemical action of the 
mobile phase. The interior of the tubing must be smooth with a very uniform bore 
diameter. Straight columns are preferred and are operated in the vertical position. 
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Columns end fitting and connectors must be designed with zero void volume to avoid 
unswept corners or stagnant pockets of mobile phase that can contribute significantly to 
extra column band broadening. Packaging is usually retained by inserting stainless steel 
frits into the end of the column. 
 Most column lengths range from 10 to 30 cm; short, fast columns are              3 
to 8 cm long. For exclusion chromatography, columns are 50 to 100 cm long. The types 
of columns use in HPLC are, 
1. Standard columns 
2. Radial compression columns 
3. Narrow-Bore columns 
4. Short, fast columns 
5. Guard columns and In - line filters 
Guard column (Douglas A. Skoog, 2005) 
Often, a short guard column is positioned ahead of the analytical column to 
increase the life of the analytical column by removing particulate matter and 
contaminants from the solvents. In addition, in liquid-liquid chromatography, the 
guard column serves to saturate the mobile phase with the stationary phase so that 
losses of the stationary phase from the analytical column are minimized. The 
composition of the guard column should be similar to that of the analytical columns, 
the particle size is usually larger, however, to minimize pressure drop. 
Detectors (Ashutoshkar, 2005) 
 The main function of the detector in HPLC is to monitor the mobile phase 
coming out of the column, which in turns emits electrical signals that are directly 
proportional to the characteristics either of the solute or the mobile phase. The various 
detectors often used in HPLC may be categorized in to 
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Bulk property detectors  
 They specifically measure the difference in some physical property of the solute 
present in the mobile phase in comparison to the individual mobile phase, for instance 
a) Refractive-index detectors 
b) Conductivity detectors. 
Solute property detectors 
 They critically respond to a particular physical or chemical characteristic of the 
solute (in question), which should be ideally and absolutely independent of the mobile 
phase being used. But complete independence of the mobile phase is hardly to be seen, 
however signal discrimination is good enough to enable distinctly measurable 
experimental procedures with solvent changes, such as gradient elution. The solute 
property detectors include 
a) UV- detectors 
b) Fluorescence detectors. 
Multipurpose detectors  
 Besides, providing a high degree of sensitivity together with a broad linear 
response attainable range invariably a particular situation critically demands detectors 
of more selective nature in the domain at „analytical chemistry‟ vis-a-vis 
„pharmaceutical analysis‟ that could be accomplished by using multipurpose detectors, 
such as “Perkin-Elmer 3D system” that combines UV absorption, fluorescence and 
conductometric detection. 
Electro chemical detectors 
 Electro chemical detector in HPLC usually refers to either amperometric or 
coulometric detectors, that specifically measure the current associated with the 
reduction or oxidation of solutes. As only a narrow spectrum of compounds undergo 
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electrochemical oxidation, such detectors are quite selective, and this selectively may 
be further enhanced by monitoring the potential applied to the detector so as to 
differentiate between various electroactive species. Naturally, electrochemical detection 
essentially makes use of conducting mobile phase, for instance, inorganic salts or 
mixtures of water with water miscible organic solvents. 
1.4 HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY 
(Sethi, P.D., 1996, Sethi, P.D., Dilip Chareganokar.1999) 
 HPTLC is the most simple separation technique today available to the analyst. It 
can be considered a time machine that can speed your work and allows you to do many 
things at a time usually not possible with other analytical techniques.  
1.4.1 Steps involved in HPTLC 
 1. Selection of HPTLC plates and sorbent 
 2. Sample preparation including any clean up and pre – chromatographic 
 derivatization 
 3. Application of sample 
 4. Development (separation) 
 5. Detection including post – chromatographic derivatization 
 6. Quantitation 
 7. Documentation 
1. Plates  
Precoated plates 
 The pre – coated plates with different support material (Glass, Aluminum and 
plastic) and with different sorbent layers are available in the different format and 
thickness by various manufacturers. Usually plates with sorbent thickness of 100 – 250 
m are used for qualitative and quantitative analysis, however for preparative TLC 
work, plates with sorbent thickness of 1.0 – 2.0 mm are available in addition to 
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chemically modified layers Aluminum Sheet (0.1 mm thick): Aluminum sheet as a 
support offer the same advantage as polyester support but with increased temperature 
resistance. However with eluents containing high concentration of mineral acids or 
concentrated ammonia, one may find problem as they will chemically attack aluminum. 
Aluminum sheets are otherwise compatible with organic solvents and organic acids 
such as formic acid and acetic acid. Aluminum Precoated plates in size of 20 x 20 cm 
are usually procured for economic reasons. These plates can be cut to size and shape 
(format) to suit particular analysis by using general purpose scissors. 
2. Pre – washing of pre – coated plates  
 Sorbents with large surface area absorb not only water vapours and other 
impurities from atmosphere but other volatile substances often condense particularly 
after the packing has been opened and exposed to laboratory atmosphere for a long 
time. Such impurities including elutable components of the binder usually give dirty 
zones and fail to give reproducible results. It is only for these reasons that pre-coated 
plates are always packed with the glass or foil side upward (coated layer downward). 
To avoid any possible interference due to impurities with the chromatographic 
separations particularly in case of quantitative work, it is always recommended to clear 
the plates before actual chromatography. This process is called pre – washing of plates. 
Excellent results are obtained if the plates are subjected to pre – washing (in cleaning 
solvent) by continuous mode for some time in a chamber closed by a lid having a slit. 
After washing, the plates must be dried for a sufficient time to ensure complete removal 
of the washing liquids (usually for methanol 30 – 60 min at 105° c is required). The 
washed plates should always be stored in a dust – free atmosphere under ambient 
conditions. As a result of pre – washing, signal to noise ratio is substantially low and 
base lines are straighter, which is essential for quantitative analysis by in situ 
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densitometry.  Plates exposed to high humidity or kept on a hand for long time may 
have to be activated by placing in oven at 110 – 120° c for 30 minutes prior to sample 
spotting. This step removes water that has been physically absorbed on the surface of 
the sorbent. 
3. Sample preparation and Application  
 The sample preparation procedure is to dissolve the dosage form with complete 
recovery of intact compounds(s) of interest and minimum of matrix with a suitable 
concentration of analyte(s) for direct application on the HPTLC plate. Sample 
application is the most critical step for obtaining good resolution for quantification by 
HPTLC. The sample should be completely transferred to the layer, however, under no 
circumstances, the application process should damage the layer, as damaged layer 
results in unevenly shaped spots. Wherever possible, use of automatic application 
devices is recommended for quantitative analysis. Usually 0.5 – 5 l for HPTLC is 
recommended keeping the size of starting zone(s) down to minimum of 0.5 – 1 mm in 
concentration range of 0.1 – 1 g/mL. substance zones which are too large from the 
beginning because poor separation as during development spots does tend to become 
large and more diffused. It is therefore recommended that solution should be applied in 
small increments with intermediate drying (use cold or hot air or nitrogen in case of 
labile compounds, asymmetric accelerated evaporation of the solvent from the point of 
application can lead to local changes in the concentration in spotted substances) 
particularly when the sample solution is predominantly  aqueous. 
4. Development (separation) 
Mobile phase 
 Poor grade of solvent used in preparing mobile phases have been found to 
decrease resolution, spot definition and Rf reproducibility. Mobile phases commonly 
35 
 
called solvent system is traditionally selected by controlled process of trial and error 
and also based on one‟s own experience in the field. Use of mobile phase containing 
more than three or four components should normally be avoided as it is often difficult 
to get reproducible ratios of different components. The chamber saturation has 
pronounced influence on the separation profile. When the plate is introduced in to an 
unsaturated chamber, during the course of development, the solvent evaporates from 
the plate mainly at the solvent front. Therefore larger quantity of the solvents shall be 
required for a given distance; hence resulting is increase in Rf values. If the tank is 
saturated ( by lining with filter paper) prior to development, solvent vapors soon get 
uniformly distributed throughout the chamber as soon as the plate is placed in such a 
saturated chamber, it soon gets pre loaded with solvent vapors, hence less solvent shall 
be required to travel a particular distance, resulting in lower Rf values. Time required 
for saturation will depend on the nature and composition of mobile phase and layer 
thickness. 
  Development in a non- saturated or partially saturated atmosphere is 
recommended with solvents used in a composition leading to phase separation such as 
mixture of n- butanol, water, glacial acetic acid. However in case of RPTLC, it is 
always preferable to saturate the chamber with methanol as normally in RPTLC, 
mobile phase with high water contents are employed. If chromatographic procedure is 
to be carried out at a controlled relative humidity of the chamber then suitable liquid is 
placed in one of the troughs of twin-trough chamber. Usually relative humidity of the 
room is controlled by dehumidifier. However, if experiments are required to be carried 
at specific relative humidity, then solution of sulphuric acid or salt solutions may be 
employed. After development the plate is removed from the chamber and mobile phase 
is removed as completely and as quickly as possible. These steps should preferably be 
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performed in fume cup board to avoid contamination of laboratory atmosphere. The 
plates should always be laid horizontally so that while mobile phase evaporates the 
separated substances will migrate evenly to the surface where they can be easily 
detected.  
Factors influencing separation of components and resolution of spots 
 Type of stationary phase – sorbent, particle size, activity 
 Type of plates 
 Layer thickness 
 pH of layer 
 Binder for layer 
 Melting point 
 Solvent purity 
 Size of chamber 
 Saturation of chamber 
 Solvent for sample phase 
 Melting point level in  chamber 
 Size of spot 
 Relative humidity 
 Temperature 
 Flow rate of solvent  
 Separation distant 
 Mode of development 
5. Detection and visualization 
 One of the most characteristic features of HPTLC is the possibility to utilize 
post chromatographic off-line derivatization. With the availability of many 
visualization reagents, findings can be confirmed. These visualization reactions are 
possible for identification even if the separation is not optimally. As soon as the 
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development process is complete, the plate is removed from the chamber and dried to 
remove the mobile phase completely. The zones can be located by various physical, 
chemical, biological- physiological methods. There is apparently no difficulty in 
detecting color substances or colorless substances absorbing in short wave UV-region 
(254 nm) or with intrinsic fluorescence such as riboflavin. The substance which do not 
have above properties has to be transferred in to detectable substances by means of 
chromogenic or fluorogenic reagents which are more expensive, time - consuming and 
complicated. Detection sensitivity depends on the specificity for the reagent employed. 
Iodine is the universal detection reagent, that detection is usually non-destructive and 
reversible but certain substances may be altered through non-reversible derivatization 
such as ethambutol, a totally non UV absorbing compound forms a UV absorbing 
complex with iodine through charge transfer. Detection under UV light is the first 
choice and is non-destructive in most of the cases and is commonly employed for 
densitometric scanning. Derivatization reactions are essentially required for detection 
when individual compound does not respond to UV or does not have intrinsic 
fluorescence. It is not significant whether derivatization is pre or post chromatographic 
however, pre-chromatographic derivatization not only helps in detection but enhances 
the selectivity of the mobile phase. For post chromatographic derivatization, smaller the 
chromatographic zone, greater the concentration of the substance leading to increase in 
detection sensitivity. Other simple detection method is based on wetting and solubility 
phenomenon. Aluminium oxide, kieselguhr, silica gel or hydrophilic adsorbents. On 
dipping or spraying the chromatogram with water, lipophillic substances such as 
steroids, fatty acids, hydrocarbons appear as white (opaque) spot against semi-
transparent back ground as such a substances being invisible with water or not wetted. 
This wetting effect is more prominent if the plate is fully saturated with water and held 
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against light. The contrast is best immediately after dipping, disappears on drying. 
Other commonly used reagents are phosphomolybdic acid, antimony trichloride or 
pentachloride, anisaldehyde - sulphuric acid, dimethyl amino benzaldehyde in sulphuric 
acid and fluorescein sodium. These reagents yield sufficient stable colored spots for 
quantitative scanning.  
6. Quantitation (evaluation) 
 Requirements for various steps in HPTLC are more stringent for quantitative 
analysis. Accurate and precise application of samples is the most critical.  Further, the 
chromatographic development should clearly and completely separate all the 
compounds of interest with no loss by decomposition, evaporation or irreversible 
adsorption during application or development.  Sample and standard as a rule should as 
a rule should be chromatographed on the same plate under similar conditions. 
 Earlier, a typical approach was scrapping the separated analyte zones from 
support material and extracting with a suitable solvent, compounds thus eluted could be 
analysed by any convenient analytical method; spectrophotometric, fluorometric or by 
suitable colour development method. To compensate for interference from the sorbent, 
usually a blank area of the layer is also eluted simultaneously and used as a blank for 
final analysis. Such blank‟s values can be lowered by pre-washing of TLC layer with 
methanol, methanol-chloroform (1:1) or methylene chloride prior to chromatographic 
procedure. However, this method of separating and elution has limited  application as 
the compounds under analysis may be irreversibly bound to the HPTLC supporter 
elution/isolation steps may cause some chemical transformation or there is likelihood of 
analyte loss during extraction. Layers containing gypsum as binder are considerably 
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softer and especially suited for preparative chromatography involving scrapping form 
plate and subsequent elution and estimation. 
In situ densitometry 
 Densitometry is the in situ instrumental measurement of visible, UV 
absorbance, fluorescence or fluorescence quenching directly on the layer without 
resorting to scrapping and elution. Since chromatographic zones remit a lower light 
intensity than the environment around it, absorption spectra can be determined directly 
on the plate by comparison with substance free area on the sorbent layer. The 
measurements are usually made by reflection from the plate using single beam, double 
beam or single beam – dual wavelength operation of scanning instruments. The purpose 
of the scanner is to convert the spot or band on the layer into chromatogram. The 
position of the scanned peaks on the recorder chart are related to Rf values of the spots 
on the layer and peak height or area is related to the concentration of the substance on 
the spot. The signals which are measured represent the adsorption of transmitted or 
reflected light that passes through the spot compared to blank portion of the sorbent 
layer. A calibration curve consisting of scan area of standard versus amount of analyte 
is constructed and amount of analyte in the sample represented by scan area is 
interpolated from the standard curve. 
Factors influencing in selection of detection wavelength 
 1. The absorption spectra of compound when recorded in solution or in situ 
from TLC plate are almost similar. Pre – recorded spectra of these compounds as 
available in literature may be considered for taking decision. 
          2. In situ spectra of each component of the formulation may be simultaneously 
considered for selecting the most suitable wavelength for scanning. 
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 3. Extinction coefficient (E 1% 1 cm) and actual concentration of a compound 
in the formulation has to be taken into consideration, particularly in respect of 
compounds with low extinction coefficient. 
 4. While selecting single wavelength, the interest of minor component in the 
formulation shall need special consideration. 
 5. If absorption maxima of individual component of the formulation are quite 
apart, then the chromatogram must be scanned at individual absorption maxima for 
obtaining meaningful results. 
7. Documentation  
 The use of application scheme and labeling every single chromatogram can 
avoid mistake in respect of order of application. It is preferable to apply each sample 
and reference solution twice by following data – pair method. A lead pencil can be used 
to write on the chromatoplate. The plate should never be marked below the starting 
point, as the layer is likely to get damaged affecting chromatographic distribution of the 
substances under analysis, which may ultimately lead to error in scanning. The best 
way to label the chromatoplate is to mark above the level of solvent point. Immediately 
after development is completed, the solvent point should be marked with both on left 
and right hand edges of the plate. To assist the analysts and researchers in practice of 
HPTLC, E. Merck has recently introduced HPTLC pre - coated plates with an 
imprinted identification code. The data needed for traceability according to HPTLC 
such as supplier‟s name, item number, batch number and individual plate number are 
imprinted near upper edge of the pre - coated plates. This will not only help in the 
traceability of analytical data, but will avoid manipulation of data at any stage as 
coding will automatically get recorded during the photo – documentation. 
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Stabilization of developed zones 
 After treatment with the reagent as part of chromatographic derivatization, 
coloured or fluorescent chromatographic zones are used for quantitative evaluation. It is 
therefore desirable that the colour or fluorescence thus produced should be stable at 
least for 30 minutes for carrying out various steps involved in quantitative analysis. 
There is no general procedure laid down to stabilize the coloured chromatographic 
zones except to store in atmosphere of nitrogen and protected from light till they are 
evaluated. However, fluorescent chromatographs can not only be stabilized but often 
intensified.        
A detailed lay out 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Sample and standard preparation  Selection of chromatographic layer 
Layer pre - washing 
Layer pre - conditioning 
Application of sample and standard 
Chromatographic development 
Detection of spots 
Scanning and documentation of chromatoplate 
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1.5 ANALYTICAL METHOD VALIDATION 
         (Code Q2A; Q2B; ICH Guidelines) 
Introduction 
This document presents a discussion of the characteristics for consideration 
during the validation of the analytical procedures included as part of registration 
applications submitted within the EC, Japan and USA.  This document does not 
necessarily seek to cover the testing that may be required for registration in, or export 
to, other areas of the world. Furthermore, this text presentation serves as a collection of 
terms, and their definitions, and is not intended to provide direction on how to 
accomplish validation.  These terms and definitions are meant to bridge the differences 
that often exist between various compendia and regulators of the EC, Japan and USA. 
The objective of validation of an analytical procedure is to demonstrate that it is 
suitable for its intended purpose.  A tabular summation of the characteristics applicable 
to identification, control of impurities and assay procedures is included.  Other 
analytical procedures may be considered in future additions to this document. 
Types of Analytical Procedures to be Validated 
The discussion of the validation of analytical procedures is directed to the four 
most common types of analytical procedures: 
  -   Identification tests 
 - Quantitative tests for impurities content 
 -  Limit tests for the control of impurities 
 -  Quantitative tests of the active moiety in samples of drug substance or drug 
product or other selected component(s) in the drug product. 
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Although there are many other analytical procedures, such as dissolution testing 
for drug products or particle size determination for drug substance, these have not been 
addressed in the initial text on validation of analytical procedures.  Validation of these 
additional analytical procedures are equally important to those listed herein and may be 
addressed in subsequent documents. 
A brief description of the types of tests considered in this document is provided 
below. 
 - Identification tests are intended to ensure the identity of an analyte in a sample.  
This is normally achieved by comparison of a property of the sample             
(e.g., spectrum, chromatographic behaviour, chemical reactivity, etc) to that of a 
reference standard 
 - Testing for impurities can be either a quantitative test or a limit test for the 
impurity in a sample.  Either test is intended to accurately reflect the purity 
characteristics of the sample. Different validation characteristics are required for 
a quantitative test than for a limit test 
 - Assay procedures are intended to measure the analyte present in a given sample.  
In the context of this document, the assay represents a quantitative measurement 
of the major component(s) in the drug substance.  For the drug product, similar 
validation characteristics also apply when assaying for the active or other  
selected component(s).  The same validation characteristics may also apply to 
assays associated with other analytical procedures (e.g., dissolution). 
The objective of the analytical procedure should be clearly understood since this will 
govern the validation characteristics which need to be evaluated.  Typical validation 
characteristics which should be considered are listed below 
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Accuracy 
Precision  
Repeatability 
Intermediate Precision 
Specificity 
Detection Limit 
Quantitation Limit 
Linearity 
Range 
Each of these validation characteristics is defined in the attached Glossary. The 
table lists those validation characteristics regarded as the most important for the 
validation of different types of analytical procedures.  This list should be considered 
typical for the analytical procedures cited but occasional exceptions should be dealt 
with on a case-by-case basis.  It should be noted that robustness is not listed in the table 
but should be considered at an appropriate stage in the development of the analytical 
procedure. 
Furthermore revalidation may be necessary in the following circumstances 
 - changes in the synthesis of the drug substance 
 - changes in the composition of the finished product 
 - changes in the analytical procedure. 
The degree of revalidation required depends on the nature of the changes. Certain 
other changes may require validation as well. 
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TABLE 
Type of analytical 
procedures 
IDENTIFICATION TESTING FOR 
IMPURITIES 
ASSAY 
- dissolution 
(measurement only) 
- content/potency 
characteristics  quantitation limit  
Accuracy - + - + 
Precision  
Repeatability 
Intermediate Precision 
 
- 
- 
 
+ - 
+ (1) - 
 
+ 
+ (1) 
Specificity (2) + + + + 
Detection Limit - - (3) + - 
Quantitation Limit - + - - 
Linearity - + - + 
Range - + - + 
- signifies that this characteristic is not normally evaluated 
    +       signifies that this characteristic is normally evaluated 
(1) In cases where reproducibility (see glossary) has been performed, intermediate 
precision is not needed 
(2)  Lack of specificity of one analytical procedure could be compensated by other 
supporting analytical procedure(s) 
(3) May be needed in some cases 
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1.5.1. GLOSSARY 
1.5.1.1. ANALYTICAL PROCEDURE 
The analytical procedure refers to the way of performing the analysis. It should 
describe in detail the steps necessary to perform each analytical test. This may include 
but is not limited to: the sample, the reference standard and the reagents preparations, 
use of the apparatus, generation of the calibration curve, use of the formulae for the 
calculation, etc. 
 1.5.1.2. SPECIFICITY 
Specificity is the ability to assess unequivocally the analyte in the presence of 
components which may be expected to be present. Typically these might include 
impurities, degradants, matrix, etc. 
Lack of specificity of an individual analytical procedure may be compensated 
by other supporting analytical procedure(s). 
This definition has the following implications: Identification: to ensure the identity of 
an analyte. 
Purity Tests: to ensure that all the analytical procedures performed allow an                    
accurate statement of the content of impurities of an analyte, i.e. related substances test, 
heavy metals, residual solvents content, etc. 
Assay (content or potency):  
                   To provide an exact result which allows an accurate statementon the 
content or potency of the analyte in a sample. 
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1.5.1.3. ACCURACY 
The accuracy of an analytical procedure expresses the closeness of agreement 
between the value which is accepted either as a conventional true value or an accepted 
reference value and the value found.This is sometimes termed trueness. 
 1.5.1.4. PRECISION  
The precision of an analytical procedure expresses the closeness of agreement 
(degree of scatter) between a series of measurements obtained from multiple sampling 
of the same homogeneous sample under the prescribed conditions. Precision may be 
considered at three levels:  repeatability, intermediate precision and reproducibility. 
Precision should be investigated using homogeneous, authentic samples. 
However, if it is not possible to obtain a homogeneous sample it may be investigated 
using artificially prepared samples or a sample solution. 
The precision of an analytical procedure is usually expressed as the variance, 
standard deviation or coefficient of variation of a series of measurements. 
1.5.1.5. Repeatability 
Repeatability expresses the precision under the same operating conditions over 
a short interval of time. Repeatability is also termed intra-assay precision. 
1.5.1.5.1. Intermediate precision 
Intermediate precision expresses within-laboratories variations: different days, 
different analysts, different equipment, etc. 
1.5.1.5.2. Reproducibility 
Reproducibility expresses the precision between laboratories (collaborative 
studies, usually applied to standardization of methodology). 
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1.5.1.6. DETECTION LIMIT  
The detection limit of an individual analytical procedure is the lowest amount of 
analyte in a sample which can be detected but not necessarily quantitated as an exact 
value. 
1.5.1.7. QUANTITATION LIMIT 
The quantitation limit of an individual analytical procedure is the lowest 
amount of analyte in a sample which can be quantitatively determined with suitable 
precision and accuracy. The quantitation limit is a parameter of quantitative assays for 
low levels of compounds in sample matrices, and is used particularly for the 
determination of impurities and/or degradation products. 
1.5.1.8. LINEARITY 
The linearity of an analytical procedure is its ability (within a given range) to 
obtain test results which are directly proportional to the concentration (amount) of 
analyte in the sample. 
1.5.1.9. RANGE 
The range of an analytical procedure is the interval between the upper and 
lower concentration (amounts) of analyte in the sample (including these 
concentrations) for which it has been demonstrated that the analytical procedure has a 
suitable level of precision, accuracy and linearity. 
1.5.1.10. ROBUSTNESS 
The robustness of an analytical procedure is a measure of its capacity to remain 
unaffected by small, but deliberate variations in method parameters and provides an 
indication of its reliability during normal usage. 
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1.5.2 VALIDATION OF ANALYTICAL PROCEDURES: METHODOLOGY 
INTRODUCTION 
This document is complementary to the parent document which presents a 
discussion of the characteristics that should be considered during the validation of 
analytical procedures. Its purpose is to provide some guidance and recommendations on 
how to consider the various validation characteristics for each analytical procedure. In 
some cases (for example, demonstration of specificity), the overall capabilities of a 
number of analytical procedures in combination may be investigated in order to ensure 
the quality of the drug substance or drug product. In addition, the document provides an 
indication of the data which should be presented in a registration application.All 
relevant data collected during validation and formulae used for calculating validation 
characteristics should be submitted and discussed as appropriate. 
Approaches other than those set forth in this guideline may be applicable and 
acceptable. It is the responsibility of the applicant to choose the validation procedure 
and protocol most suitable for their product. However it is important to remember that 
the main objective of validation of an analytical procedure is to demonstrate that the 
 procedure is suitable for its intended purpose. Due to their complex nature, analytical 
procedures for biological and biotechnological products in some cases may be 
approached differently than in this document. Well-characterized reference materials, 
with documented purity, should be used throughout the validation study. The degree of 
purity necessary depends on the intended use. 
In accordance with the parent document, and for the sake of clarity, this 
document considers the various validation characteristics in distinct sections. The 
arrangement of these sections reflects the process by which an analytical procedure 
may be developed and evaluated. 
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In practice, it is usually possible to design the experimental work such that the 
appropriate validation characteristics can be considered simultaneously to provide a 
sound, overall knowledge of the capabilities of the analytical procedure, for instance: 
specificity, linearity, range, accuracy and precision. 
SPECIFICITY 
An investigation of specificity should be conducted during the validation of 
identification tests, the determination of impurities and the assay. The procedures used 
to demonstrate specificity will depend on the intended objective of the analytical 
procedure.  
It is not always possible to demonstrate that an analytical procedure is specific 
for a particular analyte (complete discrimination). In this case a combination of two or 
more analytical procedures is recommended to achieve the necessary level of 
discrimination. 
Identification  
Suitable identification tests should be able to discriminate between compounds 
of closely related structures which are likely to be present. The discrimination of a 
procedure may be confirmed by obtaining positive results (perhaps by comparison with 
a known reference material) from samples containing the analyte, coupled with 
negative results from samples which do not contain the analyte. In addition, the 
identification test may be applied to materials structurally similar to or closely related 
to the analyte to confirm that a positive response is not obtained. The choice of such 
potentially interfering materials should be based on sound scientific judgement with a 
consideration of the interferences that could occur.  
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Assay and Impurity Test (s)  
For chromatographic procedures, representative chromatograms should be used 
to demonstrate specificity and individual components should be appropriately labelled. 
Similar considerations should be given to other separation techniques.  
Critical separations in chromatography should be investigated at an appropriate 
level. For critical separations, specificity can be demonstrated by the resolution of the 
two components which elute closest to each other. 
In cases where a non-specific assay is used, other supporting analytical 
procedures should be used to demonstrate overall specificity. For example, where a 
titration is adopted to assay the drug substance for release, the combination of the assay 
and a suitable test for impurities can be used. 
The approach is similar for both assay and impurity tests 
Impurities are available 
For the assay, this should involve demonstration of the discrimination of the 
analyte in the presence of impurities and/or excipients; practically, this can be done by 
spiking pure substances (drug substance or drug product) with appropriate levels of 
impurities and/or excipients and demonstrating that the assay result is unaffected by the 
presence of these materials (by comparison with the assay result obtained on unspiked 
samples). 
For the impurity test, the discrimination may be established by spiking drug 
substance or drug product with appropriate levels of impurities and demonstrating the 
separation of these impurities individually and/or from other components in the sample 
matrix. 
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Impurities are not available 
If impurity or degradation product standards are unavailable, specificity may be 
demonstrated by comparing the test results of samples containing impurities or 
degradation products to a second well-characterized procedure e.g. pharmacopoeial 
method or other validated analytical procedure (independent procedure). As 
appropriate, this should include samples stored under relevant stress conditions: light, 
heat, humidity, acid/base hydrolysis and oxidation.  
- for the assay, the two results should be compared; 
- for the impurity tests, the impurity profiles should be compared. 
Peak purity tests may be useful to show that the analyte chromatographic peak 
is not attributable to more than one component (e.g., diode array, mass spectrometry). 
LINEARITY 
A linear relationship should be evaluated across the range (see section 3) of the 
analytical procedure. It may be demonstrated directly on the drug substance (by 
dilution of a standard stock solution) and/or separate weighings of synthetic mixtures of 
the drug product components, using the proposed procedure. The latter aspect can be 
studied during investigation of the range. 
Linearity should be evaluated by visual inspection of a plot of signals as a 
function of analyte concentration or content. If there is a linear relationship, test results 
should be evaluated by appropriate statistical methods, for example, by calculation of a 
regression line by the method of least squares. In some cases, to obtain linearity 
between assays and sample concentrations, the test data may need to be subjected to a 
mathematical transformation prior to the regression analysis. Data from the regression 
line itself may be helpful to provide mathematical estimates of the degree of linearity.  
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The correlation coefficient, y-intercept, slope of the regression line and residual 
sum of squares should be submitted. A plot of the data should be included. In addition, 
an analysis of the deviation of the actual data points from the regression line may also 
be helpful for evaluating linearity.Some analytical procedures, such as immunoassays, 
do not demonstrate linearity after any transformation. In this case, the analytical 
response should be described by an appropriate function of the concentration (amount) 
of an analyte in a sample. For the establishment of linearity, a minimum of 5 
concentrations is recommended. Other approaches should be justified. 
RANGE  
The specified range is normally derived from linearity studies and depends on 
the intended application of the procedure. It is established by confirming that the 
analytical procedure provides an acceptable degree of linearity, accuracy and precision 
when applied to samples containing amounts of analyte within or at the extremes of the 
specified range of the analytical procedure.  
The following minimum specified ranges should be considered: 
- for the assay of a drug substance or a finished (drug) product: normally from 80 to 
120 percent of the test concentration;  
- for content uniformity, covering a minimum of 70 to 130 percent of the test 
concentration, unless a wider more appropriate range, based on the nature of the dosage 
form (e.g., metered dose inhalers), is justified; 
- for dissolution testing: +/-20 % over the specified range;  
e.g., if the specifications for a controlled released product cover a region from 20%, 
after 1 hour, up to 90%, after 24 hours, the validated range would be 0-110% of the 
label claim.  
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- for the determination of an impurity: from the reporting level of an impurity to 
120% of the specification; for impurities known to be unusually potent or to produce 
toxic or unexpected pharmacological effects, the detection/quantitation limit should be 
commensurate with the level at which the impurities must be controlled; 
Note: for validation of impurity test procedures carried out during development, it may 
be necessary to consider the range around a suggested (probable) limit. 
- if assay and purity are performed together as one test and only a 100% standard is 
used, linearity should cover the range from the reporting level of the impurities
 
to 120% 
of the assay specification. 
ACCURACY 
Accuracy should be established across the specified range of the analytical 
procedure.  
Assay 
Drug Substance 
Several methods of determining accuracy are available 
 a) application of an analytical procedure to an analyte of known purity                
(e.g. reference material) 
 b) comparison of the results of the proposed analytical procedure with 
those of a second well-characterized procedure, the accuracy of which is stated 
and/or defined (independent procedure, see 1.2.) 
 c) accuracy may be inferred once precision, linearity and specificity have 
been established. 
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Drug Product 
Several methods for determining accuracy are available 
 a) application of the analytical procedure to synthetic mixtures of the drug 
product components to which known quantities of the drug substance to be 
analysed have been added 
 b) in cases where it is impossible to obtain samples of all drug product 
components , it may be acceptable either to add known quantities of the analyte to 
the drug product or to compare the results obtained from a second, well 
characterized procedure, the accuracy of which is stated and/or defined 
(independent procedure,   see 1.2.) 
 c) accuracy may be inferred once precision, linearity and specificity have been 
established. 
Impurities (Quantitation) 
Accuracy should be assessed on samples (drug substance/drug product) spiked 
with known amounts of impurities. 
In cases where it is impossible to obtain samples of certain impurities and/or 
degradation products, it is considered acceptable to compare results obtained by an 
independent procedure (see 1.2.). The response factor of the drug substance can be 
used.It should be clear how the individual or total impurities are to be determined    
e.g., weight/weight or area percent, in all cases with respect to the major analyte. 
Recommended Data 
Accuracy should be assessed using a minimum of 9 determinations over a 
minimum of 3 concentration levels covering the specified range (e.g., 3 concentrations 
or 3 replicates each of the total analytical procedure). 
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Accuracy should be reported as percent recovery by the assay of known added 
amount of analyte in the sample or as the difference between the mean and the accepted 
true value together with the confidence intervals. 
PRECISION 
Validation of tests for assay and for quantitative determination of impurities 
includes an investigation of precision. 
Repeatability 
Repeatability should be assessed using 
 a) a minimum of 9 determinations covering the specified range for the 
procedure (e.g., 3 concentrations/3 replicates each) 
 b) a minimum of 6 determinations at 100% of the test concentration. 
Intermediate Precision 
The extent to which intermediate precision should be established depends on the 
circumstances under which the procedure is intended to be used. The applicant should 
establish the effects of random events on the precision of the analytical procedure. 
Typical variations to be studied include days, analysts, equipment, etc. It is not 
considered necessary to study these effects individually. The use of an experimental 
design (matrix) is encouraged. 
Reproducibility 
Reproducibility is assessed by means of an inter-laboratory trial. 
Reproducibility should be considered in case of the standardization of an analytical 
procedure, for instance, for inclusion of procedures in pharmacopoeias. These data are 
not part of the marketing authorization dossier.  
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Recommended Data 
The standard deviation, relative standard deviation (coefficient of variation) and 
confidence interval should be reported for each type of precision investigated. 
DETECTION LIMIT 
Several approaches for determining the detection limit are possible, depending 
on whether the procedure is a non-instrumental or instrumental. Approaches other than 
those listed below may be acceptable. 
Based on Visual Evaluation 
Visual evaluation may be used for non-instrumental methods but may also be 
used with instrumental methods. The detection limit is determined by the analysis of 
samples with known concentrations of analyte and by establishing the minimum level 
at which the analyte can be reliably detected. 
Based on Signal-to-Noise  
This approach can only be applied to analytical procedures which exhibit 
baseline noise. Determination of the signal-to-noise ratio is performed by comparing 
measured signals from samples with known low concentrations of analyte with those of 
blank samples and establishing the minimum concentration at which the analyte can be 
reliably detected. A signal-to-noise ratio between 3 or 2:1 is generally considered 
acceptable for estimating the detection limit. 
Based on the Standard Deviation of the Response and the Slope 
The detection limit (DL) may be expressed as 
DL = 3.3 σ 
 S 
where σ = the standard deviation of the response 
  S = the slope of the calibration curve 
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 The slope S may be estimated from the calibration curve of the analyte. The 
estimate of σ may be carried out in a variety of ways, for example 
Based on the Standard Deviation of the Blank 
Measurement of the magnitude of analytical background response is performed by 
analyzing an appropriate number of blank samples and calculating the standard 
deviation of these responses.  
Based on the Calibration Curve 
A specific calibration curve should be studied using samples containing an analyte in 
the range of DL. The residual standard deviation of a regression line or the standard 
deviation of y-intercepts of regression lines may be used as the standard deviation.  
Recommended Data 
The detection limit and the method used for determining the detection limit should be 
presented. If DL is determined based on visual evaluation or based on signal to noise 
ratio, the presentation of the relevant chromatograms is considered acceptable for 
justification. 
In cases where an estimated value for the detection limit is obtained by calculation or 
extrapolation, this estimate may subsequently be validated by the independent analysis 
of a suitable number of samples known to be near or prepared at the detection limit.  
QUANTITATION LIMIT 
Several approaches for determining the quantitation limit are possible, depending on 
whether the procedure is a non-instrumental or instrumental. Approaches other than 
those listed below may be acceptable. 
Based on Visual Evaluation 
Visual evaluation may be used for non-instrumental methods but may also be 
used with instrumental methods. 
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The quantitation limit is generally determined by the analysis of samples with 
known concentrations of analyte and by establishing the minimum level at which the 
analyte can be quantified with acceptable accuracy and precision.  
Based on Signal-to-Noise  
This approach can only be applied to analytical procedures that exhibit baseline 
noise. 
Determination of the signal-to-noise ratio is performed by comparing measured signals 
from samples with known low concentrations of analyte with those of blank samples 
and by establishing the minimum concentration at which the analyte can be reliably 
quantified. A typical signal-to-noise ratio is 10:1.  
Based on the Standard Deviation of the Response and the Slope 
The quantitation limit (QL) may be expressed as: 
QL = 10 σ 
 S 
where σ = the standard deviation of the response 
  S = the slope of the calibration curve 
The slope S may be estimated from the calibration curve of the analyte. The estimate of 
σ may be carried out in a variety of ways for example:  
Based on Standard Deviation of the Blank 
Measurement of the magnitude of analytical background response is performed by 
analyzing an appropriate number of blank samples and calculating the standard 
deviation of these responses.  
Based on the Calibration Curve 
A specific calibration curve should be studied using samples, containing an analyte in 
the range of QL. The residual standard deviation of a regression line or the standard 
deviation of y-intercepts of regression lines may be used as the standard deviation.  
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Recommended Data 
The quantitation limit and the method used for determining the quantitation limit 
should be presented. The limit should be subsequently validated by the analysis of a 
suitable number of samples known to be near or prepared at the quantitation limit.  
ROBUSTNESS 
The evaluation of robustness should be considered during the development phase and 
depends on the type of procedure under study. It should show the reliability of an 
analysis with respect to deliberate variations in method parameters.If measurements are 
susceptible to variations in analytical conditions, the analytical conditions should be 
suitably controlled or a precautionary statement should be included in the procedure. 
One consequence of the evaluation of robustness should be that a series of system 
suitability parameters (e.g., resolution test) is established to ensure that the validity of 
the analytical procedure is maintained whenever used. 
Examples of typical variations are 
- stability of analytical solutions; 
- extraction time. 
In the case of liquid chromatography, examples of typical variations are 
- influence of variations of pH in a mobile phase, 
- influence of variations in mobile phase composition, 
- different columns (different lots and/or suppliers), 
- temperature, 
- flow rate. 
In the case of gas-chromatography, examples of typical variations are 
- different columns (different lots and/or suppliers) 
- temperature 
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- flow rate. 
1.6.1. SYSTEM SUITABILITY TESTING 
System suitability testing is an integral part of many analytical procedures. The 
tests are based on the concept that the equipment, electronics, analytical operations and 
samples to be analyzed constitute an integral system that can be evaluated as such. 
System suitability test parameters to be established for a particular procedure depend on 
the type of procedure being validated. See Pharmacopoeias for additional information. 
Acceptance criteria of validation for HPLC 
S.NO. 
 
Characteristics Acceptance Criteria 
1 Accuracy 
 
Recovery 98 - 102% with 80,100 and 120% of 
spiked samples 
2 Precision 
a)Repeatability 
b) Intermediate precision  
 
 
RSD < 2% 
RSD < 2% 
3 Specificity/selectivity 
 
 No interference 
4 Detection limit S/N > 2 or 3 
 
5 Quantization limit S/N > 10 
 
6 Linearity r > 0.999 
 
7 Range 80 - 120% 
 
 8 Stability > 24h or > 12h 
 
 
1.6.2 SYSTEM SUITABILITY PARAMETERS 
(USP XXIII 1995; Beckett and Stenlake, 2002; Willard, 1986) 
System suitability testing is an integral part of many analytical procedures. The tests are 
based on the concept that the equipment , electronics, analytical operations and samples 
to be analyzed constitute  an integral system that can be evaluated as such  system 
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suitability test parameters to be established for a particular procedure depend on the 
type of procedures being validated. 
The parameters that are affected by the changes in chromatographic conditions are 
1) Retention time (tR) 
2) Resolution (RS) 
3) Capacity factor (k`) 
4) Selectivity (α) 
5) Number of Theoretical plates (N)  
6) HETP 
7) Asymmetry factor 
8) Tailing factor 
1) Retention time 
Chromatographic retention is to measure the time between the injection point 
and maximum of the detector response for correspondent compound. This parameter 
called “retention time” is inversely proportional to the eluent flow rate. 
2) Resolution  
The degree of separation or resolution of two adjacent band is defined as the 
distance between band peaks divided by the average band width retention and band 
width are measured in units of time. 
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Where,  
Rt1 and Rt2 are the retention times of components 1 and 2  
 
W1 and W2 are peak widths of components 1 and 2. 
 
3) Capacity factor (K’) 
It is a measure of a sample peak in the chromatogram being specific for a given 
compound, a parameter which specifies of a substance to be separated. 
 
4) Selectivity (α) 
The selectivity α is a measure of relative retention of two components in a 
mixture. The ideal value of selectivity is 2. It can be calculated by using the following 
formula. 
01
02
VV
VV


  
Where, V0 is the void volume of the column and V2 and V1 are the retention  
volumes of the second and the first peak, respectively. 
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5) Number of Theoretical plates (N) 
The number of theoretical plates N is a measure of column efficiency. For 
Gaussian peaks it is calculated by the following formula. 
2
2
16
W
Rt
N   
           Where t = retention time  
W = width of the peak its base obtained by the extrapolating relatively straight 
sides of the peak to the base line. 
W1/2 = width of the peak at the half height obtained directly by electronic 
integrators. 
The value of N depends upon the substance being chromatographed as well as 
the operating conditions such as mobile phase, temperature. 
Limit = N > 2000 is desirable. 
6) Height equivalent to a Theoretical plate (HETP) 
A theoretical plate can be of any height which decides the efficiency of 
separation. If HETP is less the column is more efficient. If HETP is more the column 
efficiency is less the equivalent to a theoretical plate (HETP) is given by 
n
columnofLength
HETP   
Where n = Number of theoretical plates. 
7) Peak asymmetry  
Peak asymmetry factor as can be used as a criterion of column performance. 
The peak half width, divided by the corresponding front half width, a gives the 
asymmetry factor 
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8) Tailing factor: 
The tailing factor T, a measure of peak symmetry, is unity for perfectly 
symmetrical peaks and its value increases as tailing becomes more pronounced. 
In some cases, values less than unity may be observed. As peak asymmetry increases, 
integration, hence precision becomes less reliable. 
𝑇 =
𝑊0.05
2𝑓
 
Where, W0.05 = Width of peak at 5% height. 
F = distance from the peak maximum to the leading edge of the peak. The 
distance being measured at a point 5% of the peak from the base line. 
            Limit ≤ 2 is preferable. 
1.7 STATICAL PARAMETERS (Mendham et al. 2002) 
1.7.1. Linear regression 
 Once linear relationship has been shown to have a high probability by the 
value of the correlation coefficient „r‟ then the best straight line through the data 
points has to be estimated. This can be often done by visual inspection of graph but 
in many cases it is far more sensible to evaluate the best straight line by linear 
regression.  
The equation of straight line is  
 
Y = mx + c 
Where, y the dependent variable is plotted as result changing x the independent 
variable. 
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 To obtain regression line „y „ on „x „ the slope „m‟ of the line intercept „c‟ on the 
y axis are given by the following formula. 
             m =
N  xy  − ( x) ( y)
N  x2− ( x)2
 
c =
( y) ( x2) – ( x) ( xy )
N  x2− ( x)2
   
1.7.2. Correlation coefficient  
The correlation co-efficient is used as a measure of the correlation between two 
variables. When variables x and y are correlated rather than being functionally related. 
The person correlation co efficient is one of the most convenient to calculate. This is 
given by 
r =
n  x1y1− x1y1
  n  x12− ( x12   n  y12− ( y12  
1
2 
 
 
Where n is the number of data points.  
The maximum, value of r is 1. When this occurs, there is exact correlation 
between the two variables. When r is zero, there is complete independence of the 
variables. The minimum value of r is -1. A negative correlation co-efficient indicates 
that the assumed dependence is opposite to what exists and therefore a positive  co-
efficient for the revered relation. The fit must be quite poor before r become smaller 
than about 0.98 and is really very poor when less than 0.9. 
1.7.3. Standard deviation 
 It is commonly used in statistics as a measure of precision and is more meaning 
full than is the average deviation. It may be thought of as a root mean square deviation 
of values from their average and is expressed mathematically as 
Where, S = Standard deviation 
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If N is large (50 or more) then of course it of immaterial whether the term in the 
denomination is N - 1 or N. 
Σ         = sum 
x        = Mean or arithmetic average. 
x -x   = Deviation of a value from the mean 
N       = Number of observations 
1.7.4. Percentage relative standard deviation (% RSD) 
 It is also known as co efficient of variation CV. It is defined as the standard 
deviation (S.D) expressed as the percentage of mean. 
                            C 100
x
S.D
RSD  %or  V   
Where 
S.D = Standard deviation 
  The variance is defined as S
2 
and is more important in statistics than S itself. 
However the latter is much more commonly used with chemical data. 
1.7.5. Standard error of mean (S.E) 
  The standard error of mean can be defined as the value obtained by the division 
of standard deviation by square root of number of observations. It is mathematically 
expressed as,  
S.E. =  
Where, 
S.D = Standard deviation. 
    n = number of observations.
n
S.D
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  2. REVIEW OF LITERATURE 
2.1. DRUG PROFILE   
(The Merck index 2006, http://toxwiki.wikispace/lacosamide.com, 
www.drugs.com/ppa/lacosamide.html )                
LACOSAMIDE 
 Molecular Structure 
NH
O
NHCH3
O
O
CH3
 
 Chemical Structure 
(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide 
 Molecular Formula  
C13H18N2O3 
 Molecular Weight  
 250.30 g/ mol 
 Description  
White to slightly yellow crystalline powder 
Category 
 Anti convulsant 
 Storage  
Tablet and liquid should be stored at 20-25 
0
C 
 Solubility 
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Freely soluble in water and in organic solvents such as Ethanol, Methanol, 
dimethyl formamide, dimethyl sulphoxide, slightly soluble in acetonitrile and soluble 
in phosphate buffered saline at pH 7.2. Practically insoluble in 0.1 M Sodium 
Hydroxide  
 Identification  
1. Melting point 
Drug Standard value Observed value* 
Lacosamide 143-144˚C 143 ˚C 
*Average of six determination. 
2. IR spectra was recorded and shown in figure 1. 
Indication  
Lacosamide is indicated as a adjunctive therapy in the treatment of partial-
onset seizure with or without secondary generalization in patient with epilepsy aged 
sixty years and olders, it is also being developed for the treatment of diabetic 
neuropathy pain. 
Pharmacodynamics  
Lacosamide has a novel dual mechanism of action. it selectively enhances 
slow inactivation of voltage-gated sodium channels. Stabilizing hyperexcitable 
neuronal membranes and inhibiting neuronal firing. In addition . it modulates 
collapsing response mediator protein-2(CRMP-2). The  role of CRMP-2 in seizures 
has not been fully elucidated, however , its expression is altered in epilepsy and other 
neurodegenerative disease. 
Pharmacokinetics  
Absorption 
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Lacosamide is rapidly completely absorbed after oral administration. The oral 
bioavailability of Lacosamide tablet is approximately 100%. Following oral 
administration, the plasma concentration of unchanged Lacosamide increases rapidly 
and reach.es Cmax about 0.5-4 hours post dose. The food does not affect the rate and 
extended of absorption. The plasma concentration increases proportional with dose 
after oral and i.v administration. 
Distribution 
  The volume of distribution is approximately 0.6 L/kg. Lacosamide is less than 
15% bound to plasma protein  
Metabolism 
Lacosamide undergoes demethylation to o- desmethyl Lacosamide, an inactive 
metabolite. 95% of dose is excreted in the urine as drug and metabolites.the major 
compounds excreted in urine are unchanged Lacosamide (approximately 40% of the 
dose) and its o-desmethyl Lacosamide metabolites less than 30% 
Elimination 
Lacosamide is primarily eliminated from the systemic circulation by renal 
excretion and biotransformation. After oral and intravenous administration of 
Lacosamide. The elimination half life is unchanged drug is approximately 13 hours. 
Approximately 95% Lacosamide administered was recovered in the urine and less 
than 0.5% in the faeces. 
Dosage and Administration  
The recommended initial dose is 50 mg / twice a day upto a maintenance dose 
of 200-400 mg/day. 
Side Effects 
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Blurred vision; dizziness; drowsiness; headache; irritability; mild itching; pain, 
or redness at the injection site; nausea; tiredness; tremor; vomiting; weakness. 
 
Drug Interactions 
The interaction with several drug has been studied. No interaction between 
Lacosamide and carbamazepine valproic acid, omeprazole, metforminl, digoxin and 
oral contraceptive containing ethinyl estrodiol and levonorgestrel has been observed. 
Additionally clinicall studies have have shown that Lacosamide does not affect 
plasma level of concomitantly administered carbamazepine levetiracetam lamotrigin, 
topiramate, valproate, and phenytoin. In in vitro studies revealed that Lacosamide at 
concentration 15 time greater than therapeutic plasma level, inhibited cyp 2c19, 
however plasma concentration were similar in poor and extensitive cyp 2c19 
metabolizer and in individual  with inhibited cyp 2c19.  
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2.2. REPORTED METHOD 
2.2.1 Kestlyn .C et al., (2011) Reported “A Simple HPLC-UV Method for the 
Determination of Lacosamide in Human Plasma”. This chromatographic method was 
achieved on ACE C18-AR column (2.1 mm x 150mm, 3.0 µm)and mobile phases 
consisting of mixtures of ammonium formate  buffer at pH 9 and acetonitrile . 
2.2.2  Usmangani .K Chhalotiya et al., (2011) Reported “Scientific Paper Stability-
Indicating Liquid Chromatographic Method for Quantification of new Anti Epileptic 
Drug Lacosamide in Bulk and Pharmaceutical Formulations”. This chromatography 
was achieved on hypersil C-18, 4.5 mm column, mobile phase containing 
Acetonitrile: Water (20:80 v/v) was used.  
2.2.3 Clare Greenaway et al., (2011) Reported “Lacosamide saliva and serum 
concentrations in patients with epilepsy” These data support the use of saliva as a 
viable alternative to serum for monitoring Lacosamide therapy in patients with 
epilepsy. Lacosamide concentrations in serum (free and total) and in saliva were 
determined by high performance liquid chromatography (HPLC).Results:Linear 
regression analysis showed a good correlation between Lacosamide dose and both 
total (r
2
 = 0.825; n = 32) and free (r
2
 = 0.815; n = 29) serum concentrations, and 
Lacosamide serum total and free concentrations were linearly related                         
(r
2
 = 0.721; n = 97). There was also a good correlation between saliva Lacosamide and 
both total (r
2
 = 0.842; n = 49) and free (r
2
 = 0.828; n = 47) serum Lacosamide 
concentrations.  
2.2.4 Soo-Jin Kim et al. (2011) reported “Liquid Chromatography-Tandem Mass 
Spectrometry for Quantification of Lacosamide, an Antiepileptic Drug, in Rat Plasma 
and its Application to Pharmacokinetic Study”. The method involves the 
addition of acetonitrile and internal standard solution to plasma samples, 
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followed by centrifugation. An aliquot of the supernatant was diluted with water and 
directly injected into the LC/MS/MS system. The separations were performed on 
column packed with octadecylsilica (5 µm, 2.0 × 50 mm) with 0.1% formic acid and 
acetonitrile as mobile phase, and the detection was performed on tandem mass 
spectrometry by the multiple-reaction monitoring via an electrospray ionization 
source. 
2.2.5 Martinez et al., (2011) Reported “High-Performance Liquid Chromatographic 
Analysis of Lacosamide in Canine Serum using Ultraviolet Detection: Application to 
Pre-Clinical Pharmacokinetics in Dogs”. A novel and simple high-performance liquid 
chromatography method was developed for determination of lacosamide in dog 
serum. Serum proteins (0.1 mL) were precipitated with -20.0°C acetonitrile after 
addition of the internal standard, daidzein. Separation was achieved with a 
Phenomenex® Luna® C(18) (2) (5 µm, 250 × 4.60 mm) column with ultraviolet 
detection at 210 nm.  
2.2.6  Kalyan chakravathy et al., (2011) reported “Development and Validation of RP-
HPLC Method for Estimation of Lacosamide in Bulk and its Pharmaceutical 
Formulation”. This chromatography was  achieved with a Develosil ODS HG-5 
Column and sodium dihydrogen phosphate monohydrate buffer :Acetonitrile         
(700: 300 v/v) as mobile phase flow rate 1.0 mL/ min Detection was performed at   
210 nm    
2.2.7 Sai sumanth et al., (2012) reported “Validated Spectrophotometric Estimation of           
Lacosamide in Bulk and Tablet Dosage Forms” using Water as solvent. Lacosamide 
has the absorbance maxima at 257 nm. Beer‟s Law was found to be obeyed                 
in the concentration range 300- 900 µg/ mL Result of the Analysis                          
were validated statistically and by Recovery studies.
  
 
 
 
 
 
 
 
 
 
Aim and plan of 
work 
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3. AIM AND PLAN OF WORK 
3.1 Aim of Work  
The drug analysis plays an important role in the development, manufacture 
and therapeutic use of drug. Most of the pharmaceutical industries do the quantitative 
chemical analysis  to ensure that the raw material used and the final product thus 
obtained meet certain specifications  and to determine how much of each components 
are present in the final product. 
 
  
Standard analytical procedure for newer drugs or formulation may not be 
available in pharmacopoeias hence it is essential to develop newer analytical methods 
which are accurate, precise, specific, linear, simple and rapid. UV and HPLC grades 
of solvents used for respective determination and solvent should readily available and 
cheaper. The solvent should be completely extracting the active ingredient from 
formulation. 
Lacosamide is indicated as a adjunctive therapy in the treatment of partial-
onset seizure with or without secondary generalization in patient with epilepsy aged 
sixty years and older, it is also being developed for the treatment of diabetic 
neuropathy pain. This is a newer drug in Indian market and CDSCO approves this 
newer drug on December 2010. 
Extensive literature survey revealed that the HPLC – UV method for the 
determination of Lacosamide in plasma has been reported. However there is no 
evidence for the estimation of Lacosamide by   UV spectrophotometry, HPTLC and 
HPLC - UV in bulk and in tablet formulation.  
Hence the present work, aims to develop a simple, precise and accurate 
methods for the estimation of Lacosamide in bulk and in pharmaceutical dosage form 
and to validate the developed methods by using UV spectroscopy, HPTLC and        
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RP – HPLC method. The developed HPLC method was compared with the reported 
methods. 
3.2 Plan of Work 
3.2.1 Survey on literature 
The survey on literature performed for Lacosamide for their physiochemical 
properties, solubility, pharmacology and analytical techniques. So this basic 
information gives notation for newer method development. 
3.2.2 Method development 
1) Identification of drug by its melting point. 
2) Determination of solubility of the drugs. 
3) Development of simple, cost effective and accurate spectrophotometric 
methods. 
4) Development of simple, cost effective and accurate HPTLC method. 
5) Development of a rapid and accurate RP – HPLC method involving 
   UV - detection. 
6) Analysis of marketed formulations. 
7) Validation of developed analytical methods. 
8) Statistical analysis of developed analytical methods. 
3.2.3 Validation of developed method 
The developed method should be validated as per ICH guidelines. The 
parameters used to validate the developed method are Accuracy, Precision, 
Specificity, Limit of Detection, Limit of Quantification, Linearity, Range, Robustness 
and Ruggedness. The system suitability parameters like Capacity factor, Asymmetric 
factor, Tailing factor, Number of theoretical plates, HETP and Resolution should be 
calculated for RP-HPLC chromatograms and compare with standard values.
  
                  
 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND 
METHODS 
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4. MATERIALS AND METHODS 
4.1 Materials 
4.1.1 Drug Samples (Raw material) 
               Lacosamide was obtained as a gift sample from Alkem pharma, Mumbai. 
4.1.2 Formulation used 
              LACOSAM tablets (Torrent pharmaceuticals, Mumbai) containing 
Lacosamide 100 mg was procured from OM pharmacy, Chennai.                   
4.1.3 Chemicals and solvents used 
           Distilled water, Potassium dihydrogen orthophosphate (AR Grade), Methanol 
(HPLC grade), Water (HPLC grade), Acetonitrile (HPLC grade), were purchased 
from Qualigens India Pvt. Limited and Loba Chemie India Limited, Mumbai. 
4.1.4 Instruments used 
  Different instruments used to carry out the present work, 
1) Shimadzu AUX - 220 Digital balance 
2) Shimadzu - 1700 Double Beam UV - Visible spectrophotometer with pair of 
10 mm matched quartz cells 
3) ELICO SL - 210 Double Beam UV - Visible spectrophotometer with pair of      
10 mm matched quartz cells 
4) ELICO pH meter (Model LI - 120) 
5) CAMAG - HPTLC Instrument 
6) THERMO SCIENTIFIC SPECTRA - HPLC system  
7) SOLTECH – Sonica ultrasonic cleaner – Model 2200 MH 
8) REMI – Centrifuge apparatus 
9) CYBERLAB – Micropipette 
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Specifications (Terms) of instruments 
a) Shimadzu AUX - 220 Digital balance (Shimadzu Instruction Manual) 
                                              Specifications 
     Weighing capacity 200 gms 
     Minimum display 0.1 mg 
     Standard deviation  0.1 mg 
     Operation temperature range 5 to 40 C 
 
b) Double Beam UV - Visible Spectrophotometer (Shimadzu and ELICO 
Instruction Manuals) 
 Model: Shimadzu UV - 1700; Double beam UV - Visible spectrophotometer. 
              ELICO SL – 210; Double beam UV - Visible spectrophotometer. 
Specification Shimadzu UV - 1700 Elico SL - 210 
Light source 
20 W halogen lamp, 
Deuterium lamp, 
Light source position 
automatic adjustment 
mechanism. Built in lamp 
lighting time display 
function. 
Tungsten halogen lamp (W), 
Deuterium lamp (D), 
Light source position 
automatic adjustment 
mechanism. 
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Monochromator  Aberration- correcting 
concave blazed holographic 
grating 
Concave holographic grating 
with 1200 lines/ mm 
Detector Silicon photodiode Photodiode 
Stray Light 0.04% or less (220 nm; 
NAI 10g/ lt) 
0.04% or less (340 nm; 
NaNo2 50g/ lt). 
< 0.05% T at 220 nm with 
NAI  10g/ lt 
Measurement  
Wavelength range 
190 ~ 1100 nm 190 ~1100 nm 
Spectral Band width 1 nm or less                   
(190 to 900nm). 
1.8 nm 
Wave length Accuracy ± 0.5 nm on broad 
automatic wavelength 
calibration mechanism. 
± 0.5 nm automatic 
wavelength calibration 
mechanism. 
Recording range Absorbance;                           
- 3.99 ~ 3.99 Abs 
Transmittance;                                                              
- 399 ~ 399% 
Absorbance; ± 3.000 Abs 
 
Photometric accuracy ± 0.004 Abs (at 1.0 Abs). 
± 0.002 Abs (at 0.5 Abs). 
± 0.005 Abs (at 1.0 Abs). 
± 0.010 Abs (at 0.5 Abs). 
Operating  
Temperature/ 
Humidity 
 
Temperature range; 15 to 
35˚C 
Humidity range; 
35 to 80% (15 to below 
35˚C) 
35 to 70% (30 to below 
35˚C) 
Temperature range; 15 to 
35˚C 
Humidity range; 
35 to 80% (15 to below 
35˚C) 
35 to 70% (30 to below 
35˚C) 
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INSTRUMENT SPECIFICATION FOR HPLC 
THERMO SCIENTIFIC SPECTRA HPLC system 
Pump p4000 
auto sampler as3000 
UV-VIS detector uv 2000 
vaccum degasser scm 1000 
system controller sn 4000 
sample cooler up to 2-4° c 
soft ware chrom quest 5.0 
 
A) HPTLC INSTRUMENT – CAMAG SPECIFICATION 
Sample Applicator Linomat IV with Camag 100 µL Syringe 
Chamber Camag Twin trough glass chmber (20× 
Scanner Camag TLC Scanner III 
Software Wincat software  
Development temperature Ambient 
Stationary Phase HPTLC plates (Merck) precoated with 
silica gel 60 F 254 on Aluminium sheets  
Development time  20 min 
 
       4.2 METHODS 
 In the present work an attempt was made to develop and validate simple, 
precise and accurate methods for the estimation of Lacosamide in pure form and in 
tablet dosage form by  
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1)  First  Order Derivative Spectrophotometric Method  
2) RP – HPLC Method 
3) HPTLC method 
4.2.1 First Order Derivative Spectroscopic Method 
 This method involves the conversion of normal spectra to its first derivative 
spectrum. The absorption spectra is referred to as the Fundamental, zeros order or Dº 
spectrum. The first derivative (Dº) spectrum is a plot of the state of change of absorbance 
with wavelength, i.e a plot of the slope of the fundamental spectrum against wavelength or 
a plot of da/ dλ vs λ The absorbances of a number of standard solutions of the reference 
substance of the concentration encomparing the sample concentration are measured and a 
calibration graph is constructed. The concentration of the sample solution is read from the 
graph as the concentration corresponding to the absorbance of the solution 
4.1.2.1. Selection of solvent 
             The solubility of Lacosamide was determined in a variety of solvents as per 
Indian pharmacopoeia standards. Solubility was carried out in polar and non polar 
solvents. From the solubility data Distilled Water was selected as solvent for the 
analysis of Lacosamide. 
4.1.2.2.Preparation of standard stock solution 
 10 mg of Lacosamide raw material was weighed accurately and transferred in 
to 10 mL volumetric flask and dissolved in Distilled Water and made up to the 
volume with Distilled Water. This solution contains 1000 µg / mL concentration.  
4.1.2.3.Selection of wavelengths for estimation and stability studies 
 The standard stock solution was further diluted with Distilled Water to get the 
concentration of 10 µg/ mL and the solution was scanned between 200 and 400 nm 
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using Distilled Water as blank. The spectra was derivatised to first order and from the 
spectra, 216.5 nm was selected as an analytical wavelength.  
 The stability was performed by measuring the solution at different time 
intervals. It was observed that Lacosamide in Distilled Water was stable for up to       
4 hours at the selected wavelength. 
4.1.2.4.Preparation of calibration graph 
 The standard stock solution of Lacosamide (1mL – 5 mL) was transferred into 
series of 100 mL volumetric flasks and made up to the volume with Distilled Water. 
The absorbance of different concentration solutions were measured at 216.5 nm. The 
calibration curve was constructed by plotting concentration Vs absorbance. 
Lacosamide was linear with the concentration range of 10 – 50 g/ mL at 216.5 nm. 
4.1.2.5.Quantification of raw material 
 3 mL of standard stock solution was taken in to series of six 100 mL standard 
flasks and the volume was made up to mark with Distilled Water. The absorbance of 
these solutions was measured at 216.5 nm. The amount Lacosamide present in the raw 
material was determined by using slope and intercept values from calibration graph.   
4.1.2.6.Quantification of formulation 
 10 tablets of formulation (LACOSAM) containing Lacosamide equivalent to       
100 mg were weighed accurately and the average weight of each tablet was found. 
The tablets were ground to a fine powder. The tablet powder equivalent to 50 mg of 
Lacosamide was weighed and transferred into 50 mL volumetric flask. Added a 
minimum quantity of Distilled Water to dissolve the substance and the solution was 
sonicated for 15 minutes. The volume was made up to 50 ml with distilled water. The 
solution was centrifuged for 15 minutes and the supernatant liquid was filtered 
through Whatmann filter paper No. 41. From the clear solution, further dilutions were 
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made by diluting 3 mL into 100 mL with Distilled Water to obtain 30 g/ mL solution 
theoretically. The absorbances of six replicates were measured and the amount was 
calculated by using regression equation. This procedure was repeated for six times. 
4.1.2.7. Recovery studies 
a) Preparation of Lacosamide raw material stock solution 
 100 mg of Lacosamide was accurately weighed and transferred into 10 mL 
Volumetric flask and sufficient Distilled Water was added to dissolve the substance 
and made up to the mark with the same. This contains 10 mg / mL concentration.  
b) Procedure 
 The recovery experiment was done by adding known concentrations of raw 
material stock solution of Lacosamide to the preanalyzed formulation. The tablet 
powder equivalent to 50 mg of Lacosamide was weighed accurately and added 4mL, 
5 mL and 6 mL of above raw material stock solution into a series of 50 mL standard 
flasks and dissolved with Distilled Water and the solution was sonicated for 15 
minutes. The volume was made up to 50 mL with distilled water. The solution was 
centrifuged for 15 minutes at 2000 rpm and the supernatant liquid was filtered 
through a Whatmann filter paper No.41. 3 mL of the clear solution was transferred 
into 100 mL volumetric flask and made up to 100 mL with Distilled Water. The 
absorbance of three replicates was measured at the selected wavelength. The amount 
of drug recovered from formulation was calculated. The procedure was repeated for 
three times for each concentration.  
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4.1.2.7.1. Validation of developed method  
4.1.2.7.2. Linearity 
 A calibration curve was plotted between concentration and absorbance. 
Lacosamide was linear in the concentration range of 10 – 50 g/ mL of Lacosamide at 
216.5 nm.  
4.1.2.7.3.Precision 
 The repeatability of the method was confirmed by the analysis of formulation 
was repeated for six times with the same concentration. The amount of drug present in 
the tablet formulation was calculated.  The percentage RSD was calculated. The 
intermediate precision of the method was confirmed by intraday and interday analysis 
i.e. the analysis of formulation was repeated three times in the same day and on three 
successive days. The amount of drugs was determined and the percentage RSD also 
calculated.     
4.1.2.7.3. Accuracy (Recovery studies) 
 Accuracy of the method was confirmed by recovery studies. To the 
preanalyzed formulation, a known quantity of raw material of Lacosamide was added 
and the procedure was followed as per the analysis of formulation. The amount of 
each drug recovered was calculated. This procedure was repeated for three times for 
each concentration. The % RSD was calculated. 
4.1.2.7.4. Ruggedness  
 Ruggedness of the method was confirmed by the analysis of formulation was 
done by using different instruments and different analysts. The amount and % RSD 
were calculated. 
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4.1.2.7.5. LOD and LOQ 
 The linearity study was carried out for six times. The LOD and LOQ were 
calculated based upon the calibration curve method.  
The LOD and LOQ were calculated by using the average of slope and standard 
deviation of intercept. 
4.2.3 REVERSE PHASE – HPLC METHOD 
4.2.3.1. Selection of chromatographic method 
        Proper selection of the method depends upon the nature of sample, polarity, 
molecular weight, pka value and solubility. The drug Lacosamide for the present 
study was polar. So, reverse phase chromatographic technique was selected by using 
Intersil ODS- 3V column as a stationary phase with different ratios of 50Mm 
Potassium dihydrogen orthophosphate: Acetonitrile: Methanol as a mobile phase. 
4.2.3.2. Preparation of mobile phase 
  The mobile phase was prepared by mixing Acetonitrile with 50 mM Potassium 
Dihydrogen Ortho Phosphate and Methanol in the ratio of 10: 30: 60 % v/v and 
sonicated for 15 minutes to degas the mobile phase.  
4.2.3.3. Method development and optimization of chromatographic conditions 
4.2.3.3.1. Preparation of standard stock solution for RP-HPLC 
 100 mg of Lacosamide raw material was accurately weighed and transferred 
into 100 mL volumetric flask and dissolved in methanol (HPLC grade), after 
dissolution the volume was made up to the mark with methanol (HPLC grade). The 
solution was observed to contain 1000 µg/ mL.   
4.2.3.3.2. Selection of Detection wavelength 
 Solution of Lacosamide (10 g/ mL) was made by diluting the stock solution 
in the mobile phase of 50mM Potassium Dihydrogen Orthophosphate: Acetonitrile: 
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Methanol (30: 10: 60 % v/v/v) and scanned in the UV region of 200 – 400 nm and 
recorded the spectrum. From spectra at 210 nm the drug showed maximum 
absorbance. Hence this was selected as a detection wavelength for better sensitivity.  
4.2.3.3.3. Stability of sample solutions 
           The stability was performed by measuring the absorbance of same solution at 
different time intervals. It was found that Lacosamide was stable up to three hours. 
4.2.3.4 Optimization of chromatographic conditions 
4.2.3.4.1 Initial separation conditions 
  The following chromatographic conditions were preset initially to get better 
resolution of Lacosamide. 
Mode of operation - Isocratic 
Stationary phase - Intersil ODS- 3V Column 
                                                       (150 mm  4.6 mm i.d. 5) 
Mobile phase - 50mM Potassium Dihydrogen Orthophosphate: 
                                              Acetonitrile: Methanol.                  
Proportion of mobile phase -       (50: 40: 10 % v/v/v) 
Detection wavelength - 210 nm 
Flow rate - 1 mL/ min 
Temperature - Ambient 
Sample load - 20 l 
Operating pressure - 2000 psi 
 Method -       External Standard Calibration method 
 The mobile phase was primarily allowed to run for 60 minutes to record a 
steady baseline. The solution of Lacosamide was injected and the respective 
chromatogram was recorded. It was found that Lacosamide was eluted at 1.36 minutes 
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and the peak splitting was observed. For this reason different ratios of mobile phase 
with different solvents were tried to obtain good chromatogram with acceptable 
system suitability parameters. 
4.2.3.4.2 Selection of mobile phase 
           Different mixtures of mobile phase with different ratios were selected and their 
chromatograms were recorded, they include the following 
S.No Mobile phase Observation 
1. 
50mM Potassium Dihydrogen 
Orthophosphate: Acetonitrile: 
Methanol (50:40:10%v/v/v) 
 
Lacosamide was eluted with less retention 
time. Peak splitting was observed. 
2 
50mM Potassium Dihydrogen 
Orthophosphate: Acetonitrile: 
Methanol (50: 20: 30% v/v/v)  
A broad peak was observed. 
3 
   50mM Potassium Dihydrogen 
Orthophosphate: Acetonitrile: 
Methanol  (30:10:50%v/v/v) 
Lacosamide was eluted with less retention 
time. 
 From the above information, in the mobile phase of 50mM Potassium 
dihydrogen orthophosphate: Acetonitrile: Methanol (30: 10: 60 % v/v/v), the drug was 
eluted with sharp peak. Hence this mobile phase was used for the analysis of 
Lacosamide.   
4.2.3.4.3 Optimized Chromatographic Conditions 
Mode of operation - Isocratic 
Stationary phase - Intersil ODS- 3V Column  
                                                   (150 mm  4.6 mm i.d. 5) 
 87 
 
Mobile phase - 50mM Potassium Dihydrogen Orthophosphate:        
                                                        Acetonitrile: Methanol   
Proportion of mobile phase - 30: 10: 60 % v/v/v 
Detection wavelength - 210 nm 
Flow rate - 1 mL/ min 
Temperature - Ambient 
Sample load - 20 l 
Operating pressure - 2000 psi 
Method -       External Standard Calibration method          
4.2.3.4.4 Preparation of standard stock solution 
 100 mg of Lacosamide raw material was weighed and transferred into 100 mL 
volumetric flask, dissolved in methanol (HPLC grade) and made up to the volume 
with same. The solution contains 1 mg/ mL of Lacosamide. 
4.2.3.4.5 Preparation of Calibration graph 
 In this method, the aliquots of 0.7 – 1.3 mL of standard stock solution of 
Lacosamide were transferred into a series of 10 mL volumetric flasks and made up to 
the mark with mobile phase. The solutions containing the concentrations of              
70 - 130 g/ mL of Lacosamide. All the solutions were injected and the 
chromatograms were recorded at 210 nm. The above concentration range was found 
to be linear and obeys Beer‟s law. The procedure was repeated for three times. The 
peak areas were plotted against concentration and the calibration curve was 
constructed. 
4.2.3.4.6 Estimation of Lacosamide in tablet formulation 
 Ten tablets (LACOSAM) tablets were weighed accurately. The average 
weight was found and powdered. The tablet powder equivalent to 100 mg of 
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Lacosamide was weighed and transferred into 100 mL volumetric flask and added a 
minimum quantity of methanol (HPLC grade) to dissolve the substance and the 
solution was sonicated for 15 minutes. The solution was made up to 100 mL with 
methanol. The solution was centrifuged at 2000 rpm for 15 minutes and filtered 
through Wattmann filter Paper No: 41. 
4.2.3.4.6.1 Assay Procedure  
 8, 10, 12 mL of test solution was transferred into nine 100 mL volumetric 
flasks (three for each concentration i.e., Low level, Mid level and High level) and 
made up to the mark with mobile phase. A steady base line was recorded with 
optimized chromatographic conditions. After the stabilization of base line for 30 
minutes, nine test solutions of formulation were injected and recorded the 
chromatograms. The concentration of each test solution was determined by using peak 
area values from the calibration graph. 
4.2.3.4.7 Recovery Experiments  
4.2.3.4.7.1 Preparation Lacosamide raw material stock solution 
 An accurately weighed quantity of 400 mg of Lacosamide was transferred into 
10 mL volumetric flask and added sufficient methanol (HPLC grade) to dissolve the 
substance and made up to the mark with the same. This contains 40 mg/ mL 
concentration.  
4.2.3.4.7.2 Procedure 
 The recovery experiment was done by adding known concentrations of raw 
material stock solution of Lacosamide to the preanalyzed formulation. The tablet 
powder equivalent to 100 mg of Lacosamide was weighed accurately and added 2mL, 
2.5 mL, and 3 mL of raw material stock solution into the same 100 mL standard flasks 
individually and dissolved in methanol and the solution was sonicated for 15 minutes. 
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The solution was made up to 100 mL with methanol. The solution was centrifuged for  
15 minutes at 2000 rpm and the solution was filtered through Whatmann filter Paper 
No: 41 and made up to volume with mobile phase. The procedure was repeated as per 
the analysis of formulation. The amount of drug recovered was calculated by using 
slope and intercept valves from the calibration graph.   
4.2.3.4.8 Validation  
4.2.3.4.8.1 Linearity 
 A calibration curve was plotted between concentration and peak area. 
Lacosamide was linear in the concentration range of 70 – 130 g/ mL of Lacosamide.  
4.2.3.4.8.2 Precision 
 The repeatability of the method was confirmed by the analysis of formulation 
was repeated for six times with the same concentration. The amount of drug present in 
the tablet formulation was calculated. The percentage RSD was calculated. The 
intermediate precision of the method was confirmed by intraday and interday analysis 
i.e. the analysis of formulation was repeated three times in the same day and on three 
successive days. The amount of drugs was determined and the percentage RSD also 
calculated.     
4.2.3.4.8.3 Accuracy (Recovery studies) 
 Accuracy of the method was confirmed by recovery studies. To the 
preanalyzed formulation, a known quantity of raw material of Lacosamide was added 
and the procedure was followed as per the analysis of formulation. The amount of 
each drug recovered was calculated. This procedure was repeated for three times for 
each concentration. The % RSD was calculated. 
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4.2.3.4.8.4. LOD and LOQ 
 The linearity study was carried out for six times. The LOD and LOQ were 
calculated based upon the calibration curve method. The LOD and LOQ were 
calculated by using the average of peak area and standard deviation of intercept. 
4.2.4 HPTLC Method 
In HPTLC, the separation of the components of a mixture is based upon the 
principle of adsorption. HPTLC is differing from the TLC in the size of the silica gel 
used as the stationary phase, automated sampling application and detection. In the 
present study, a twin trough chamber and silica gel 60 F 254 plates were used. 
4.2.4.1 Optimization of chromatographic method 
The initial separation conditions used for the separation of Lacosamide are as 
follows. 
Stationary Phase  -  silica gel 60 F 254 on Aluminium sheet  
Mobile Phase   - Methanol: Ammonia    
Ratio    - 5:4 % v/v 
Detection    - UV light 
Temperature   - 30° C 
Chamber    - Twin Trough Chamber 
Development Mode   - Ascending Mode 
The mobile phase was allowed to saturate for 20 minutes in the chamber. 1 l 
volume of 1mg/ mL solution was spotted on the plates and developed the 
chromatograms. 
4.2.4.1.1. Selection of Mobile Phase 
Different mixtures of mobile phase were tried to choose the best mobile phase 
for the analysis. They include the following 
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 Methanol: Ammonia (5:4 % v/v/) 
Methanol: Water (5:5 % v/v) 
Chloroform: Water (4: 6% v/v) 
Acetonitrile: Water (4: 6 % v/v) 
From the above list of mobile phase the mobile phase Acetonitrile: Water      
(8:2 % v/v/) was found to be a better mobile phase. The drug was eluted with good 
peak. 
4.2.4.1.2. Selection of detection wavelength 
 The spectrum of Lacosamide was recorded in the selected mobile phase. 257 nm 
was selected as detection wave length where the absorbance was maximum. 
4.2.4.1.3. Optimized Chromatographic Conditions 
After conforming with the mobile phase and the detection wavelength, the 
optimized conditions for the method was as follows, 
Stationary Phase - Silica Gel 60 F 254 HPTLC Plates 
Mobile Phase  - Acetonitrile: Water  
Ratio   - (8:2 % v/v/) 
Detection  - CAMAG TLC Scanner 3, at 257 nm 
Temperature  - Ambient 
Chamber  - Twin Trough Chamber 
Development Mode - Ascending Mode 
4.2.4.2. Preparation of standard stock solution 
10 mg of Lacosamide was weighed accurately and transferred into a 10 mL 
volumetric flask. Dissolved in methanol and the volume was made up to 10 mL with 
methanol to get a concentration of 1mg / mL. 
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4.2.4.3. Linearity and Calibration Curve 
Form the standard solution 1 – 6 µL were spotted at regular intervals in the plate 
to get a concentration range of 1to 6 µg/ μl of Lacosamide. The plates were developed 
and the calibration graph was plotted using peak area versus concentration. 
4.2.4.4. Quantification of formulation 
Twenty tablets were weighed accurately and the average weight of each tablet 
was determined. The tablets were crushed into fine powder. The tablet powder 
equivalent to 50 mg of Lacosamide was weighed in to a 50 mL volumetric flask, 
dissolved in methanol, sonicated for 15 minutes and made up to 50 mL with methanol. 
This solution was centrifuged for 15 minutes at 2000 rpm. The solution was filtered 
through a Whatmann filter paper No. 41. Six 3 μl spots were placed on the plates and 
the chromatograms were recorded. From the peak area the amount of the drug was 
calculated. 
4.2.4.5. Recovery studies 
4.2.4.5.1. Preparation of Lacosamide raw material stock solution 
40 mg of Lacosamide raw material was weighed in to a 10 mL volumetric flask, 
dissolved well with methanol and made up to 10 mL with methanol to get the 
concentration of 4 mg/ mL. 
4.2.4.5.2 Procedure 
The recovery experiment was done by adding known concentrations of raw 
material stock solution of Lacosamide to the preanalyzed formulation. Tablet powder 
equivalent to 10 mg of Lacosamide was weighed in to three separate 10 mL volumetric 
flasks and dissolved in methanol, to this added 2 mL, 2.5 mL and 3 mL of Lacosamide 
raw material stock solution. Sonicated for 15 minutes and made up to 10 mL with 
methanol. This solution was centrifuged for 15 minutes at 2000 rpm. The solution was 
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filtered through a Whatmann filter paper  No. 41. From the clear solution, 3 µl spot was 
placed from each flask and the chromatograms were recorded. The amount of drug 
recovered was calculated. The procedure was reported for three times. 
4.2.4.6. Validation  
4.2.4.6.1 Linearity 
 A calibration curve was plotted between concentration and peak area. 
Lacosamide was linear in the concentration range of 1-6 g/ L of Lacosamide.  
4.2.4.6.2 Precision 
 The repeatability of the method was confirmed by the analysis of formulation 
was repeated for six times with the same concentration. The amount of drug present in 
the tablet formulation was calculated. The percentage RSD was calculated. The 
intermediate precision of the method was confirmed by intraday and interday analysis 
i.e. the analysis of formulation was repeated three times in the same day and on three 
successive days. The amount of drugs was determined and the percentage RSD also 
calculated.     
4.2.4.6.3. Accuracy (Recovery studies) 
 Accuracy of the method was confirmed by recovery studies. To the 
preanalyzed formulation, a known quantity of raw material of Lacosamide was added 
and the procedure was followed as per the analysis of formulation. The amount of 
each drug recovered was calculated. This procedure was repeated for three times for 
each concentration. The % RSD was calculated. 
4.2.4.6.4. LOD and LOQ 
 The linearity study was carried out for six times. The LOD and LOQ were 
calculated based upon the calibration curve method. The LOD and LOQ were 
calculated by using the average of slope and standard deviation of intercept.
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5. RESULTS AND DISCUSSION 
 Three methods were performed and developed for estimation of Lacosamide 
in bulk pure form and in tablet dosage form. The method are employed for analysis of 
Lacosamide were  
   5.1 First order Derivative spectrophotometric method  
   5.2RP-HPLC method 
   5.3HPTLC method 
5.1 First order Derivative Spectrophotometric method 
The identification of Lacosamide was confirmed by melting point analysis and 
IR spectral studies as shown in figure 1 and the solubility profile for Lacosamide was 
tried with various solvents (as in table 1) and Distilled water was selected as solvent.   
The zero order spectrums were derivatized into first order derivative spectrum. The 
first order derivative spectrum of Lacosamide was recorded as shown in Figure 2. 
From the spectrum, 216.5 nm was selected for the estimation of Lacosamide, which 
has maximum absorbance at this wavelength. Aliquots of Lacosamide were prepared 
in the concentration range of 10 - 50 µg / mL. The Δa/Δλ value of these solutions was 
measured at 216.5 nm in the first order derivative spectrum for Lacosamide. The 
plotted calibration curve was shown in Figure 3. The preparation of calibration curve 
was repeated for six times at their selective wavelength. The calibration curve was 
plotted using concentration against Δa/Δλ. The optical parameters like Sandell‟s 
sensitivity, Molar absorptivity, correlation coefficient, slope, intercept, LOD, LOQ 
and Standard error were calculated. The correlation coefficient of the drug was found 
to be above 0.9998. This indicates that the drug obeys Beer‟s law and it was linear at 
the selected concentration range. The results are shown in Table 2.  
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 For Quantification, the concentration of solution containing 30µg/ mL of 
Lacosamide was selected, prepared and measured at the selected wavelength. The 
amount of six test solutions was determined and the percentage purity of tablets was 
found to be 99.55 ± 1.1795 for Lacosamide. The amount present in tablets was in 
good concord with the label claim and the % RSD values were found to be 1.1848 for 
Lacosamide. The results of analysis are shown in Table 3. The low % RSD values 
indicate that the method has good precision.  
Further, the precision of the method was confirmed by Intraday and Interday 
analysis. The analysis of tablets was carried out for three times in the same day and 
one time in the three consecutive days. The % RSD value for Intraday and Interday 
analysis were 0.4124 and 0.1986 for Lacosamide, respectively. The results of analysis 
are shown in Table 4 and 5. Hence the precision was confirmed.  
            The developed method was validated for Ruggedness. In the present work, 
ruggedness was confirmed by different analysts. The % RSD value by analyst 1 and 
analyst 2 were found to be 0.1243 and 0.0813 for Lacosamide, respectively. By 
instrument 1 and instrument 2 were found to be 0.1118 and 0.0905, respectively. The 
low % RSD value indicates that the developed method was more rugged. The results 
are shown in Table 6 and 7. 
 The accuracy of the method was performed by recovery studies. To the  
preanalysed formulation, a known quantity of Lacosamide raw material solutions was 
added at three different concentration levels. The absorbance of the solutions was 
measured and the percentage recovery was calculated. The percentage recovery was 
found to be in the range of 99.18 – 99.89 %. The average % RSD value of was found 
to be 0.5069. The low % RSD values of the drug reveals that the method was more 
accurate. The recovery data was shown in Table 8. 
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5.2 RP - HPLC Method 
An exertion has been made to simple, precise, rapid, specific and accurate 
method for the estimation of Lacosamide in pure form and in formulation by            
RP – HPLC method.   
The solution of 10 g/ mL of Lacosamide in mobile phase                              
was prepared and the solution was scanned in the range of 200 – 400 nm. At 210 nm 
the drug showed maximum absorbance and it was selected as detection wavelength 
for estimation of Lacosamide by RP – HPLC method with isocratic elution technique 
and it was found to be stable up to 3 hours 30 minutes. 
Based up on the properties of the drug the initial separation was achieved by 
using different mobile phase with different compositions and the tried the mobile 
phase consists of 50Mm Potassium Dihydrogen Orthophosphate: Acetonitrile: 
Methanol (50: 40: 10 % v/v/v, 30: 20: 50 % v/v/ v and 50: 20: 30 % v/ v/ v) was 
initially tried and chromatograms were recorded.  
 At 50: 40: 10 % v/v ratio, the drug was eluted with broad, splitted peak and at           
30: 20: 50 % v/v the peak for Lacosamide was observed with tailing and in 50Mm 
Potassium dihydrogen Orthophosphate : Acetonitrile: Methanol (50: 20: 30 % v/v/v ) 
composition a sharp peak with slight tailing was observed. This is shown in figure 4, 
5 and 6 respectively. 
   Finally for HPLC Analysis the selected mobile phase was 50 Mm Potassium 
dihydrogen orthophosphate :Acetonitrile: Methanol in the ratio of 30: 10: 60 % v/v/v 
with  a retention time of 2.697 minutes  as shown in figure 7.The system suitability 
parameters for optimized chromatogram are shown in table 9.  
With the optimized chromatographic conditions, stock solutions of 
Lacosamide were prepared by using methanol (for first dilution only) and mobile 
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phase in the concentrations in the range of 70 -130 g/ mL. The chromatograms are 
shown in the figure 8 - 14 
 The calibration curve was plotted using concentration against peak area. The 
procedure was repeated for three times.  The correlation co-efficient value was found 
to be 0.9997. The calibration graph is shown in figure 15. The optical characteristics 
like correlation coefficient, slope, intercept, LOD, LOQ were calculated and are 
shown in table 10. 
The tablet formulation (LACOSAM) was selected for the analysis. The 
nominal concentration (100 g/ mL) from calibration curve was prepared in mobile 
phase. 20 µl quantity of formulation was injected and the chromatogram was 
recorded. The chromatograms are shown in figures 16 - 24. The percentage purity of 
Lacosamide present in formulation was found to be 99.47% ± 0.3760. The % RSD 
value was found to be 0.3768 and it indicates that the method has good precision. The 
values are shown in table 11. 
The accuracy of the method was performed by recovery studies. To the 
preanalyzed formulation a known quantity of Lacosamide raw material solution was 
added at three different concentrations (80%, 100% and 120%) and solution were 
injected. The chromatograms were recorded and are shown in the figures 25 -27. The 
percentage recovery was found to be in the range of 99.59 % to 100.41% of 
Lacosamide. The % RSD values were found to be 0.4455. The Low % RSD values 
indicated that there are no interferences due to the excipients used in formulation 
during the analysis of Lacosamide from tablet formulation. Hence the method was 
found to be accurate. The recovery data is shown in table 12. 
The system suitability parameters and all the validation parameters were 
found to be within the limit. Hence, this method can be effectively applied for the 
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estimation of Lacosamide in pure and in pharmaceutical dosage form than the 
reported methods. 
5.3 HPTLC METHOD 
The initial separation was made using various mobile phase using chloroform, 
methanol, formic acid, acetic acid, ammonia and water in different combinations. The 
mobile phases tried were Methanol: Ammonia (6: 4 % v/v), chloroform: Water (4:6).                   
Methanol: Water (5: 5 % v/v) and Acetonitrile: water (4:6 % v/v) were tried. 
 In Methanol: Ammonia (6:4 % v/v) the drug was separated and the Rf value 
found to be 0.90 The Rf value of Lacosamide was beyond the normal values (range 
from 0.2 to 0.8), (P.D Sethi et al). Hence the different ratios were tried with the same 
mobile phase.  Acetonitrile: Water in the ratio of 8:2 % v/v was selected for the method 
since, the drug was eluted with good resolution. 257 nm was selected as the detection 
wavelength for the analysis. The spectral conformation of the standard Lacosamide with 
sample solution Lacosamide is given in figure 28. 
1 mg/ mL stock solution of Lacosamide was prepared in methanol. From the 
stock solution concentration range of 1µg to 6µg/ spot of Lacosamide chromatogram 
were developed in the Twin trough Chamber. The linearity chromatograms are shown 
in figure 29- 34.  The calibration graph was plotted with concentration versus peak area 
and the correlation coefficient was found to be 0.9992 for Lacosamide. The calibration 
graph for Lacosamide was shown in figure 35. The optical characteristics such as the 
LOD, LOQ, Slope, Intercept, Regression equation and correlation coefficient are given 
in table 13. 
The method was applied for the analysis of formulation. The percentage purity 
of Lacosamide was found to be 99.13% ± 1.1737. The % RSD values for Lacosamide 
1.1840. The precision of the method was confirmed by the repeatable analysis of 
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formulation for six times. The chromatograms are given in figures 36 - 41. The data is 
given in table 14.  
The intermediate precision of the method was confirmed by Intraday and Inter 
day analysis. The analysis of formulation was repeated for three times in the same day 
and one time in the three successive days. The percentage RSD value for intraday and 
inter day analysis of Lacosamide was found to be 0.3502 and 1.4218, respectively. The 
reports of analysis are shown in tables 15 and 16, respectively. The results showed that 
the precision of the method was further confirmed.  
The accuracy of the method is confirmed by the recovery analysis. To the pre-
analyzed formulation, known quantities of the standard drugs were added at three 
different concentrations. The amount of Lacosamide recovered was in the range of 
99.09 % to 102.36%. The %RSD values were found to be 1.6790. The low % RSD 
values indicate that there is no interference of the excipients during the analysis. The 
peaks of the developed chromatograms are given in figures 42 - 44.The data of recovery 
analysis are given in table 17. 
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6. SUMMARY AND CONCLUSION 
 
Three methods were performed and developed for estimation of Lacosamide in bulk 
pure form and in tablet dosage form. The method are employed for analysis of 
Lacosamide were  
   6.1 First order Derivative spectrophotometric method  
   6.2 RP-HPLC method 
   6.3 HPTLC method 
6.1 First Order Derivative Spectroscopy 
From the solubility profile Distilled water was chosen as a solvent for the 
estimation of Lacosamide. The sample solution of 10 g/ mL of Lacosamide in 
Distilled water was prepared and the solution was scanned in UV region in the 
wavelength range from 200 to 400 nm by using methanol as blank. From the spectra, 
Lacosamide shows maximum absorbance at 216.5 nm.   
          The percentage label claim present in capsule formulation was found to be                  
99.55 ± 1.1795%. The percentage recovery was found to be in the range of            
99.18 – 99.89 %. 
6.2 RP-HPLC METHOD 
 
An exertion has been made for a simple, precise, rapid, specific and accurate 
method for the estimation of Lacosamide in pure form and in formulation by             
RP – HPLC method.                        
After optimizing the mobile phase, with the consideration of the system 
suitability parameters, 50 mM Potassium Dihydrogen Orthophosphate: Acetonitrile: 
Methanol in the ratio of 50: 20: 30 % v/v was selected as mobile phase for the 
analysis.  
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With the optimized chromatographic conditions, the drug was linear in the 
concentration range of 70 - 130 g/ ml. The correlation coefficient was found to be 
0.9993.  
The percentage purity of Lacosamide present in formulation was found to be 
99.74 ± 0.3760. The precision of the method was confirmed by repeatability of 
formulation for six times. 
The percentage recovery was found to be in the range of 99.59 – 100.41. 
6.3 HPTLC METHOD 
A simple and rapid HPTLC method was developed for Lacosamide in bulk and 
in tablet dosage form. The mobile phase consisting of Acetonitrile: water in the ratio of 
8:2 % v/v was selected for the analysis. From the spectral characteristics, 257 nm was 
selected as the detection wavelength for the analysis. With the optimised conditions, the 
linearity range was fixed as 1 to 6 g/ μl for Lacosamide. The correlation coefficient for 
the Lacosamide was found to be 0.9992. 
LACOSAM tablets were selected for analysis. The percentage label claim 
present in the tablet formulation was found to be 99.13 ± 1.1737 of Lacosamide. The 
precision of the method was confirmed by the reported analysis of formulation. The 
%RSD was found to be 1.1840. 
Further precision of the method was confirmed by Intraday and Inter day 
analysis. The percentage RSD value of the intraday and inter day analysis of 
Lacosamide was found to be 0.3502 and 1.4218 respectively. 
The accuracy of the method was confirmed by recovery studies. The percentage 
recovery was found to be in the range of 99.09 % to 102.36% of Lacosamide. 
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Three simple, rapid and accurate methods like First order derivative 
spectrophotometric method, isocratic RP – HPLC method and HPTLC method were 
developed for the determination of Lacosamide in bulk and in tablet formulation. The 
methods showed excellent sensitivity, reproducibility, accuracy and repeatability, 
which is evidenced by low percentage relative standard deviation values. The results 
obtained in recovery studies were indicating that there is no interference from the 
excipients used in the formulation. By comparing three methods, UV spectroscopic 
method was found to be economic when compared to RP – HPLC and HPTLC. 
Because the solvents and column used in RP – HPLC and HPTLC are very costly. 
When comparing the sensitivity of the methods, RP – HPLC and HPTLC methods 
were found to be more sensitive than UV spectroscopic method. Because the linearity 
range, LOD and LOQ were less. Hence it is suggested that the proposed                   
UV spectroscopic method, HPTLC method and RP - HPLC method can be effectively 
applied for the routine analysis of Lacosamide in bulk and in tablet formulation. 
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FIGURE-2 
FIRST ORDER DERIVATIVE SPECTRUM OF LACOSAMIDE 
IN DISTILLED WATER 
 
 
 
 
                                                             
 
 
 
 
 
 
  
 
FIGURE-3 
CALIBRATION CURVE OF LACOSAMIDE BY FIRST ORDER 
DERIVATIVE SPECTROPHOTOMETRIC METHOD USING DISTILLED 
WATER 
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                                                                       FIGURE-4 
CHROMATOGRAM FOR THE EFFECT OF RATIO OF MOBILE PHASE OF 
LACOSAMIDE 50Mm POTASSIUM DIHYDROGEN ORTHRO 
PHOSPHATE: ACETONITRILE: METHANOL (50:40:10) 
       
 
 
 
 
                                                 
 
 
  
 
                                             FIGURE-5 
CHROMATOGRAM FOR THE EFFFECT OF RATIO OF MOBILE PHASE 
OF LACOSAMIDE 50Mm POTASSIUM DIHYDROGEN ORTHRO 
PHOSPHATE: ACETONITRILE: METHANOL (30:20:50) 
 
 
 
 
 
 
  
 
FIGURE-6 
CHROMATOGRAM FOR THE EFFFECT OF RATIO OF MOBILE PHASE 
OF LACOSAMIDE 50Mm POTASSIUM DIHYDROGEN ORTHRO 
PHOSPHATE: ACETONITRILE: METHANOL (50:20:30) 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
FIGURE-7 
OPTIMIZED CHROMATOGRAM OF LACOSAMIDE 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
                                                FIGURE-8 
LINEARITY CHROMATOGRAM OF LACOSAMIDE 
BY RP-HPLC (70 µg/ mL) 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
FIGURE-9 
LINEARITY CHROMATOGRAM OF LACOSAMIDE 
BY RP-HPLC (80 µg/ mL) 
 
 
 
  
 
FIGURE-10 
LINEARITY CHROMATOGRAM OF LACOSAMIDE  
BY RP-HPLC (90 µg/ mL) 
 
 
 
 
  
 
FIGURE-11 
LINEARITY CHROMATOGRAM OF LACOSAMIDE  
BY RP-HPLC (100 µg/ mL) 
 
 
 
                                                               
 
  
 
FIGURE-12 
LINEARITY CHROMATOGRAM OF LACOSAMIDE  
BY RP-HPLC (110 µg/ mL) 
 
                                                                
 
 
  
 
FIGURE-13 
LINEARITY CHROMATOGRAM OF LACOSAMIDE  
BY RP-HPLC (120 µg/ mL) 
 
 
 
 
  
 
FIGURE-14 
LINEARITY CHROMATOGRAM OF LACOSAMIDE  
BY RP-HPLC (130 µg/ mL) 
 
 
 
 
  
 
FIGURE-15 
CALIBRATION CURVE OF LACOSAMIDE BY RP-HPLC 
 
 
 
 
 
 
 
 
 
 
                                                                     
 
 
 
  
 
 
FIGURE-16 
CHROMATOGRAM FOR ANALYSIS OF FORMULATION (LACOSAM) 
REPEATABILITY 1 
 
 
 
                                                                         
  
 
 
FIGURE-17 
CHROMATOGRAM FOR ANALYSIS OF FORMULATION  (LACOSAM) 
REPEATABILITY 2
 
 
 
 
  
 
 
FIGURE-18 
CHROMATOGRAM FOR ANALYSIS OF FORMULATION (LACOSAM) 
REPEATABILITY 3 
 
 
 
                                                           
  
 
 
FIGURE-19 
CHROMATOGRAM FOR ANALYSIS OF FORMULATION (LACOSAM) 
REPEATABILITY 4 
 
 
 
 
  
 
 
FIGURE-20 
CHROMATOGRAM FOR ANALYSIS OF FORMULATION (LACOSAM) 
REPEATABILITY 5 
 
 
 
 
  
 
 
FIGURE-21 
CHROMATOGRAM FOR ANALYSIS OF FORMULATION (LACOSAM ) 
REPEATABILITY 6 
 
 
 
 
 
  
 
 
 
FIGURE-22 
CHROMATOGRAM FOR ANALYSIS OF FORMULATION (LACOSAM ) 
REPEATABILITY 7 
 
 
 
  
 
 
 
FIGURE-23 
CHROMATOGRAM FOR ANALYSIS OF FORMULATION (LACOSAM) 
REPEATABILITY 8 
 
 
 
  
 
 
 
FIGURE-24 
CHROMATOGRAM FOR ANALYSIS OF FORMULATION (LACOSAM) 
REPEATABILITY 9 
 
 
 
 
  
 
 
FIGURE-25 
CHROMATOGRAM FOR FIRST RECOVERY ANALYSIS OF  
FORMULATION ( LACOSAM )    
 
 
 
 
  
 
                                                              
FIGURE-26 
CHROMATOGRAM FOR SECOND RECOVERY ANALYSIS OF 
FORMULATION ( LACOSAM ) 
 
 
 
  
 
 
FIGURE-27 
CHROMATOGRAM FOR THIRD RECOVERY ANALYSIS OF 
FORMULATION (LACOSAM) 
 
 
                                                          
  
 
 
FIGURE-28 
SELECTION OF DETECTION WAVELENGTH BY HPTLC 
 
 
 
 
                                                  
 
 
 
 
 
 
 
 
 
 
  
 
 
FIGURE-29 
LINEARITY CHROMATOGRAM OF LACOSAMIDE  
BY HPTLC (1 µg/ mL) 
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FIGURE-30 
LINEARITY CHROMATOGRAM OF LACOSAMIDE 
 BY HPTLC (2 µg/ mL) 
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                                              FIGURE-31 
LINEARITY CHROMATOGRAM OF LACOSAMIDE 
BY HPTLC (3 µg/ mL) 
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                                                          FIGURE-32 
LINEARITY CHROMATOGRAM OF LACOSAMIDE 
BY HPTLC (4 µg/ mL) 
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                                                                  FIGURE-33 
LINEARITY CHROMATOGRAM OF LACOSAMIDE 
BY HPTLC (5 µg/ mL) 
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                                                                 FIGURE-34 
LINEARITY CHROMATOGRAM OF LACOSAMIDE 
BY HPTLC (6 µg/ mL) 
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FIGURE-35 
CALIBRATION CURVE OF LACOSAMIDE 
BY HPTLC 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
FIGURE-36 
CHROMATOGRAM FOR THE ANALYSIS OF LACOSAMIDE 
FORMULATION (LACOSAM) 
REPEATABILITY-1 
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FIGURE-37 
CHROMATOGRAM ANALYSIS FOR THE OF LACOSAMIDE 
FORMULATION (LACOSAM) REPEATABILITY-2 
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FIGURE-38 
CHROMATOGRAM ANALYSIS FOR THE OF LACOSAMIDE 
FORMULATION (LACOSAM) REPEATABILITY-3 
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FIGURE-39 
CHROMATOGRAM ANALYSIS FOR THE OF LACOSAMIDE 
FORMULATION (LACOSAM) REPEATABILITY-4 
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FIGURE-40 
CHROMATOGRAM ANALYSIS FOR THE OF LACOSAMIDE  
FORMULATION (LACOSAM) REPEATABILITY-5 
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FIGURE-41 
CHROMATOGRAM ANALYSIS FOR THE OF LACOSAMIDE 
FORMULATION (LACOSAM) REPEATABILITY-6 
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FIGURE-42 
CHROMATOGRAM FOR FIRST RECOVERY ANALYSIS OF    
FORMULATION (LACOSAM) BY HPTLC 
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FIGURE-43 
CHROMATOGRAM FOR SECOND RECOVERY ANALYSIS OF    
FORMULATION (LACOSAM) BY HPTLC 
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FIGURE-44 
CHROMATOGRAM FOR THIRD RECOVERY ANALYSIS OF    
FORMULATION (LACOSAM) BY HPTLC 
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TABLE 1 
 
SOLUBILITY PROFILE OF LACOSAMIDE IN POLAR AND NON POLAR 
SOLVENTS 
 
S.NO SOLVENT EXTENT OF 
SOLUBILITY 
CONCLUSION 
1 Distilled water 10 mg in 400µl Sparingly soluble 
2 Benzene 10 mg in 10 mL Slightly soluble 
3 Methanol 10 mg in 50µl Freely soluble 
4 Dimethyl formamide 10 mg in 50µl Freely soluble 
5 Chloroform 10 mg in 50µl Freely soluble 
6 Ethanol 10 mg in 300µl Soluble 
7 Acetonitrile 10 mg in 50µl Freely soluble 
8 Toluene 10 mg in 10mL Very slightly soluble 
9 Acetone 10 mg in 50µl Freely soluble 
10 Ethyl acetate 10 mg in 50µl Freely soluble 
11 Isopropyl alcohol 10 mg in 50µl Freely soluble 
12 n-butanol 10 mg in 50µl Freely soluble 
13 Diethyl ether 10 mg in 3mL Slightly soluble 
14 Dil. Acetic acid 10 mg in 5mL  Slightly soluble 
15 Phosphate buffer pH 8.5 10 mg in 2mL Slightly soluble 
16 0.1M hydrochloric acid 10 mg in 2mL Slightly soluble 
17 Carbon tetra chloride 10 mg in more than 10mL  Practically insoluble 
18 Distilled Water 10mg in more than 100mL  Practically insoluble 
19 Dimethylsulphoxide 10 mg in 50µl Freely soluble 
 
  
 
TABLE 2 
OPTICAL CHARACTERISTICS OF LACOSAMIDE BY FIRST ORDER 
DERIVATIVE SPECTROPHOTOMETRIC METHOD 
                      
S.NO PARAMETERS DERIVATIVES 
1 max (nm) 216.5 nm 
2 Beers law limit (µg/mL) 10-50 
3 Correlation coefficient (r) 0.999878769 
4 Regression equation (y=mx+c) 
Y=0.003420429x-
0.000875397 
5 Slope (m) 0.003461429 
6 Intercept (c) 0.000875397 
7 LOD (µg/mL) 0.32951216.53 
8 LOQ(µg/mL) 0.998522132 
9 Sandell s sensitivity (µg/cm
2
 0.001A.U) 0.292400562 
10 Standard error of mean 0.000183206 
 
                                                             
 
 
 
 
  
 
 
 
 
  
 
 
TABLE 3 
QUANTIFICATION OF FORMULATION (LACOSAM) BY 
 FIRST ORDER DERIVATIVE SPECTROPHOTOMETRIC METHOD                                                       
 
 
 
 
 
 
 
 
 
 
 
 
S. 
No 
Labeled 
Amount 
Amount 
Found 
% 
Obtained 
Average  
 % 
Found 
S.D % 
 R.S.D 
S.E 
1 100 mg 97.97 mg 97.97 
99.55 1.1795 1.1848 0.0327 
2 100 mg 100.7 mg 100.7 
3 100 mg 100.7 mg 100.7 
4 100 mg 98.27 mg 98.27 
5 100 mg 99.93 mg 99.93 
6 100 mg 99.73 mg 99.73 
  
 
TABLE 4 
INTRADAY PRECISION ANALYSIS OF FORMULATION (LACOSAM) BY 
FIRST ORDER DERIVATIVE SPECTROPHOTOMETRIC METHOD 
 
 
*mean of three observation  
 
                                                                                             
 
 
 
                                           
 
 
 
 
 
 
 
 
 
Drug  
S. 
No 
Labeled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab) 
Percentage 
obtained 
Average 
percentage 
S.D 
% 
R.S.D 
S.E 
L
ac
o
sa
m
id
e 
 
1 100 101.4 101.40 
100.93 0.4163 0.4124 0.0462 2 100 100.8 100.80 
3 100 100.6 100.60 
  
 
                                                       TABLE 5 
INTERDAY PRECISION ANALYSIS OF FORMULATION 
( LACOSAM) BY FIRST ORDER DERIVATIVE  SPECTROPHOTOMETRIC 
METHOD 
 
Drug S.No 
Labeled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab) 
Percentage 
obtained 
Avg 
% 
S.D 
% 
R.S.D 
S.E 
L
ac
o
sa
m
id
e 
1 100 100.9 100.90 
100.7 0.2 0.1986 0.0222 2 100 100.7 100.70 
3 100 100.5 100.50 
 
mean of three observation 
 
                                                                   
                                                       
 
 
 
 
 
 
 
 
 
 
  
 
TABLE 6 
RUGGEDNESS ANALYSIS OF FORMULATION (LACOSAM 100 MG) BY     
FIRST ORDER DERIVATIVE SPECTROPHOTOMETRIC METHOD 
Drug Condition 
Sample 
No 
Labelled 
Amount 
(Mg/Tab) 
Amount 
Found 
(Mg/Tab) 
Avg  (%) 
Obtained 
S.D 
% 
R.S.D 
S.E 
L
ac
o
sa
m
id
e 
 
 
 
 
 
ANALYST 
1 
1 100 100.70 
100.56 0.1250 0.1243 0.0034 
2 100 100.60 
3 100 100.43 
4 100 100.50 
5 100 100.70 
6 100 100.43 
 
 
 
 
ANALYST 
2 
1 100 100.43 
100.36 0.0816 0.0813 0.0022 
2 100 100.33 
3 100 100.43 
4 100 100.33 
5 100 100.23 
6 100 100.43 
 
Mean of six observation 
                                                                
 
 
 
 
  
 
TABLE 7 
RUGGEDNESS ANALYSIS OF FORMULATION (LACOSAM 100 MG) BY 
FIRST ORDER DERIVATIVE SPECTROPHOTOMETRIC METHOD 
Drug Condition 
Sample 
No 
Labelled 
Amount 
(Mg/Tab) 
Amount 
Found 
(Mg/Tab) 
Avg (%) 
Obtained 
S.D 
% 
R.S.D 
S.E 
L
ac
o
sa
m
id
e 
Instrument 
1 
1 100 100.60 
100.51 0.1124 0.1118 0.0031 
2 100 100.43 
3 100 100.60 
4 100 100.50 
5 100 100.33 
6 100 100.60 
Instrument 
2 
1 100 100.43 
100.46 0.0909 0.0905 0.0025 
2 100 100.50 
3 100 100.33 
4 100 100.60 
5 100 100.43 
6 100 100.50 
 
 
 
 
 
 
 
                                                         
  
 
                                                        TABLE 8 
RECOVERY STUDIES FORMULATION (LACOSAM 100 MG) BY               
DERIVATIVE SPECTROPHOTOMETRIC METHOD 
 
 
mean of three observation 
 
 
 
 
 
 
 
Drug % 
Amt 
present 
(µg/mL
) 
Amt 
added 
(µg/mL
) 
Amt 
estimated 
Amt 
recovery 
% 
recovery 
Avg 
% 
recove
ry 
S.D 
% 
R.S.D 
S.E 
L
ac
o
sa
m
id
e 
80 
14.92 24 38.80 23.88 99.50 
99.81 0.2936 0.2941 0.032 14.92 24 38.89 23.97 99.87 
14.92 24 38.94 24.02 100.08 
100 
14.92 30 44.56 29.64 98.80 
99.18 1.0356 1.0441 0.115 14.92 30 44.44 29.52 98.40 
14.92 30 45.03 30.11 100.36 
120 
14.92 36 50.87 35.95 99.80 
99.89 0.1824 0.1826 0.020 14.92 36 50.96 36.04 100.1 
14.92 36 50.84 35.92 99.77 
  
 
 
                                                            TABLE 9 
SYSTEM SUITABILITY PARAMETERS FOR THE OPTIMIZED 
CHROMATOGRAM BY RP - HPLC 
 
Parameters Lacosamide 
Retention time 2.690 
Tailing factor 1.26 
Asymmetrical factor 1.50 
Theoretical plates 1536 
Capacity factor 1.7 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
                                                        TABLE 10 
OPTICAL CHARACTERISTICS OF LACOSAMIDE BY RP – HPLC 
 
Parameters Lacosamide 
max (nm) 210 
Beers law limit (μg/mL) 70 -130 
Correlation coefficient ® 0.9997 
Regression equation 
(y=mx+c) 
y= 23347.4513x + 
126139.6429 
Slope (m) 23347.4513 
Intercept (C) 126139.6429 
LOD (μg/mL) 0.20919 
LOQ (μg/mL) 0.633912 
Standard Error 15287.54312 
 
 
 
  
 
 
                                                       TABLE - 11 
ANALYSIS OF TABLET FORMULATION (LACOSAM) BY RP-HPLC 
 
Drug 
Sample 
ID. 
Labeled 
amount 
(mg/tab) 
Amount found 
(mg/tab)
* 
Percentage 
Obtained
* 
Average 
(%) 
S.D 
% 
R.S.D. 
S.E. 
 
 
 
 
LAC 
 
 
Low level 1 
Low level 2 
Low level 3 
Middle level 4 
Middle level 5 
Middle level 6 
High level 7 
High level 8 
High level 9 
 
100 
100 
100 
100 
100 
100 
100 
100 
100 
 
99.208 
100.204 
99.023 
99.423 
99.550 
99.381 
99.069 
99.705 
99.755 
 
99.20 
100.20 
99.02 
99.42 
99.55 
99.38 
99.06 
99.70 
99.75 
 
 
 
 
99.47 
 
 
 
 
 
0.3760 
 
 
 
 
0.3768 
 
 
 
 
0.0046 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
                                                        TABLE 12 
RECOVERY STUDY DATA OF 100 % PREANALYZED FORMULATION 
(LACOSAM) BY RP-HPLC 
Drug 
Amount 
present 
(mcg/mL) 
Amount 
added 
(mcg/mL) 
Amount 
estimated 
(mcg/mL) 
Amount 
recovered 
(mcg/mL) 
% 
Recovery 
S.D 
% 
R.S.D 
S.E. 
 
LAC 
 
100 
100 
100 
10 
20 
30 
109.521 
119.398 
129.391 
10.041 
19.918 
29.911 
100.41 
99.59 
99.70 
0.4450 0.4455 0.0494 
 
                                                  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
                              
TABLE 13 
OPTICAL CHARACTERISTIC OF LACOSAMIDE BY HPTLC      
METHOD 
 
S.NO PARAMETERS VALUES 
1 max (nm) 257 nm 
2 Beers law limit (ng/mL) 1000-6000 
3 Correlation coefficient (r) 0.9992 
4 Regression equation (y=mx+c) Y=954.79X+97.63 
5 Slope (m) 954.79 
6 Intercept (c) 97.63 
7 LOD (µg/mL) 0.0540 
8 LOD (µg/mL) 0.1638 
9 
Sandell s sensitivity (µg/cm
2
 
0.001A.U) 
1.047 
10 Standard error of mean 2.3559 
 
 
 
 
 
  
 
 
                                                            TABLE 14 
QUANTIFICATION OF FORMULATION (LACOSAM) BY HPTLC 
METHOD 
 
S.No Labeled 
Amount 
Amount 
Found 
Percentage 
Obtained 
Avg 
% 
S.D % 
R.S.D 
S.E 
1 
2 
3 
4 
 
5 
 
6 
50 mg 
50 mg 
50 mg 
50mg 
 
50mg 
 
50mg 
49.56 mg 
49.23 mg 
50.19 mg 
50.13 mg 
 
48.70 mg 
 
49.08 mg 
99.13 
99.47 
100.38 
100.26 
 
97.40 
 
98.16 
99.13 1.1737 1.1840 0.03260 
 mean of six observation 
                                                              
 
 
 
 
 
 
 
 
  
 
       
TABLE 15 
INTRADAY PRECISION ANALYSIS OF FORMULATION 
(LACOSAM) BY HPTLC METHOD 
 
Drug S.No 
Labeled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab) 
Percentage 
obtained 
Average 
percentage 
S.D 
% 
R.S.D 
S.E 
L
ac
 
1 
50 
 
49.08 98.16 
98.30 0.3442 0.3502 0.0382 2 50 49.03 98.06 
3 50 49.39 98.70 
 
mean of three observation 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
TABLE 16 
INTERDAY PRECISION ANALYSIS OF FORMULATION 
( LACOSAM ) BY HPTLC  METHOD 
 
Drug S.No 
Labeled 
amount 
(mg/tab) 
Amount 
found 
(mg/tab) 
Percentage 
obtained 
Average 
percentage 
S.D 
% 
R.S.D 
S.E 
L
ac
o
sa
m
id
e 
1 50 49.39 98.78 
99.54 1.4153 1.4218 0.1572 2 50 50.59 101.18 
3 50 49.34 98.68 
 
mean of three observation  
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
TABLE 17 
RECOVERY STUDIES FORMULATION (LACOSAM 50 MG) BY HPTLC 
METHOD 
Drug % 
Amount 
present 
(µg/mL) 
Amount 
added 
(µg/mL) 
Amt 
found 
Amt 
recovery 
% 
recovery 
Avg 
% 
recovery 
S.D 
% 
R.S.D 
S.E 
L
ac
o
sa
m
id
e 
80 
 
 
3.015 2.4 5.3932 2.3782 99.09     
100 3.015 3.0 6.0161 3.001 100.00 100.36 1.687 1.679 0.187 
120 3.015 3.6 6.700 3.685 102.36     
mean of three observation 
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